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DECISION-MAKERS’ CONCEPTUALIZATION AND FOSTERING OF COMMUNITY ENGAGEMENT 
FOR IMPROVED ADOPTION AND UPTAKE OF EXISTING AND EMERGING VACCINES IN INDIA 
 
India has introduced several vaccines and intensified decentralized vaccine delivery 
during the Decade of Vaccines (2010-2020). Alongside, there is high-level consensus that 
community engagement (CE) improves vaccination uptake and reduces burden of vaccine-
preventable diseases. Despite progresses, existing evidence showcase lack of appropriate CE 
resulting in communities’ resistance and backlashes leading to lower vaccination uptake. In 
addition, there is no evidence regarding ‘what’ vaccine decision-makers think regarding CE, and 
‘if’ communities are engaged beyond individual decisions to vaccinate themselves and their   
children. This is problematic, because assuming a shared understanding of CE will only lead to 
erroneous assumptions about its value, or lack thereof.  
 
This study uses three-stage concurrent and sequential qualitative methods to examine 
decision-makers’ conceptualization of CE, and barriers and enablers to implement CE during the 
Decade of Vaccines. Twenty-five elite interviews among national-level vaccine decision-makers 
was triangulated with content analysis of 24 vaccine policy documents and researcher field 
notes. Participant follow-up meetings was convened from December 2018 to January 2019. 
Findings were reported using Social Ecological Model (SEM). 
 
Decision-makers conceptualized communities variously: vaccine-eligible children, their 
parents, local-level vaccination influencers like health-workers, religious leaders, NGOs and 
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CBOs. The study identified broad spectrum of CE, expanding from the utilitarian-empowerment 
dichotomy. CE evolution ranged from house-to-house polio delivery to tailored interventions 
and information dissemination for vaccination among vaccine-eligible and resistant 
communities.  
 
CE barriers exceeded enablers at all SEM levels. Policy-level enablers included political-
will promoting social mobilization, whereas lack of a CE strategy was barrier. At organizational-
level, cascade training of health-workers was considered a facilitator, whereas intrinsic power-
relations within communities, and paternalistic attitude of authorities with communities were 
inhibitors. Partnerships with local organizations though acknowledged, their lack of 
institutionalization was a CE barrier at the organizational-level. At interpersonal-level, social-
behavioral change communication and social-media messaging influenced communities’ 
vaccination decisions. However, impromptu rumor management tactics and lack of strategies 
to replicate CE best practices hindered engagement. Participants recommended developing 
operational definition of CE in the vaccine arena. 
 
Future studies should codify CE and its process-indicators in policy documents. 
Studies should map CE within intersectionalities to tailor strategies such that 
efficacious vaccines become effective vaccinations among communities.  
Doctoral Committee:  Beth E. Meyerson, M.Div., Ph.D. 
Priscilla A. Barnes, M.P.H. Ph.D. 
Jon D. Agley, M.P.H., Ph.D. 
Catherine Sherwood-Laughlin, M.P.H., H.S.D. 
Jill Nicholson-Crotty, M.A., Ph.D. 
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Immunization Programs and Vaccine Delivery in India  
Vaccines are lauded as one of the greatest public health interventions because they 
reduce the burden of infectious diseases. India has made tremendous progress during the aptly 
named ‘Decade of Vaccines’ (2010-2020) by introducing multiple new vaccines along with 
striving to increase access to new and underused vaccines in the country (Paul & Sahoo, 2015). 
Currently vaccine delivery in India is mandated through the Expanded Program on 
Immunization (EPI), which was rolled out in 1985 and later renamed as the Universal 
Immunization Program (UIP) (Bhatnagar et al. 2016). The UIP consists of vaccination for 12 
diseases and available free of charge for all children and pregnant women in the country. These 
vaccines prevent tuberculosis, diphtheria, pertussis (whooping cough), tetanus, poliomyelitis, 
measles, hepatitis B, diarrhea, Japanese Encephalitis, rubella, pneumonia (Heamophilus 
Influenza Type B) and pneumococcal diseases (Pneumococcal Pneumonia and Meningitis) 
(Government of India, Ministry of Health and Family Welfare website; Travasso, 2015). To 
strengthen and invigorate the immunization program and achieve full immunization coverage 
at a rapid pace, the Government of India, in partnership with the World Health Organization 
(WHO), United Nations Children Education Fund (UNICEF), and other agencies launched Mission 
Indradhanush (MI) in December 2014 (NHP Admin, Ministry of Health and Family Welfare, June 
18, 2018). MI includes interventions to increase full immunization coverage from 65% of 
children in 2013 to at least 90% in the next five years; targeting vaccinations for diphtheria, 
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whooping cough, tetanus, poliomyelitis, tuberculosis, measles, Hepatitis B and Haemophilus 
influenza Type B (PAHO 2013, Immunity Tales, 2015). The Indian Government has also 
introduced multiple new vaccines and increased access to new and underused vaccine in 201 
districts where nearly 50% of all unvaccinated or partially vaccinated children of the country 
live. Of these districts, 82 (40.7%) are in just four states - Uttar Pradesh, Bihar, Madhya Pradesh 
and Rajasthan (Vaccine Confidence Project, 2017; Dey, Times of India, May 2016,). As part of 
the program, the Japanese encephalitis vaccine was launched in 2013, inactivated polio vaccine 
introduced in 2015, the rotavirus vaccine in 2016, measles-rubella vaccine in 2017, and twice 
during 2010 and 2016 there were attempts to introduce Human Papilloma Virus (HPV) through 
demonstration and pilot projects in five states of the country (Bagla, 2013, PATH, 2011). In 
addition, current discussions regarding the Pneumococcal, Dengue, and Meningitis vaccines 
highlight different stages in their development and introduction trajectory in the country (Paul 
and Sahoo, 2015; PMIIndia, 2014). For example, pneumococcal conjugate vaccine is supposed 
to be available in the States of Himachal Pradesh, Bihar, Uttar Pradesh, Madhya Pradesh and 
Rajasthan (PTI, 2016; The Hindu, May 2017). The dengue vaccine by Sanofi Pasteur is currently 
under review by policymakers, and another indigenous dengue vaccine developed by the 
International Centre for Genetic Engineering and Biotechnology (ICGEB) in collaboration with 
Sun Pharmaceutical Industries Limited is in the pre-clinical trial stage (Sharma, July 2017). The 
Meningococcal vaccine is recommended by the Indian Academy of Pediatrics (IAP) only for 
certain high-risk group of children, during outbreaks and international travelers (Indian 
Academy of Pediatrics website; Das, 2004). 
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Even with the recent significant changes in the strategic environment for immunization, 
including developments in new vaccines, increasing investments towards health system 
integration and decentralization, India fares very poorly in terms of vaccine utilization 
(Chatterjee et al. 2016; Laxminarayan and Ganguly, 2011). Recent numbers reveal that, only 
65% children have been immunized through UIP in the first year of their life, with an annual 
increase in coverage averaging only by 1% in the past 5 years (Mathew, 2012; Patel & Nowalk 
2009). The coverage is particularly sub-optimal for all basic vaccinations (BCG, measles, three 
doses each of diphtheria, pertussis and tetanus (DPT) and polio vaccines, excluding polio 
vaccines given at birth); with around 56% of partially immunized and un-immunized children 
under the country’s UIP (Laxminarayan & Ganguly 2011). Again, a recent report by Tripathi in 
the Impatient Optimists (Bill and Melinda Gates Foundation (BMGF), 2015) notes that out of 
the 27 million vaccine eligible children born annually in the country, 8.9 million (or 32.9%) had 
received partial or no vaccination. Of these, 8.9 million, 7.2 million children were partially 
vaccinated for seven life-threatening diseases and 1.7 million (19.1% of all vaccine eligible 
children) were totally unreached leading to a huge burden of vaccine-preventable disease 
outbreaks (Tripathi, Impatient Optimists, April 10, 2015). Thus, understanding the barriers to 
vaccine utilization possibly having their bearing to CE, and rooted in social, cultural, religious 
and political contexts, is very pertinent (Goldstein et al., 2015; Obregan et al., 2009). 
Explanations offered for these outcomes include recurring incidents of community’s skepticism 
and lack of vaccine support seen in vaccine resistance, recriminations and backlashes by the 
communities such as covert to overt vaccine resistance ranging from people closing their doors 
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and windows when they heard vaccinators approaching, to physical strife between vaccinators 
and communities (Larson, 2011). 
 
The vaccine history of India is a story of complex, top-down policy and planning with 
decentralized delivery mechanisms. This means that the vaccine policy in India is guided by 
national policy, funded by the Ministry of Health and Family Welfare (MoHFW), and supported 
by the MoHFW Departments and country offices of international donor and technical 
organizations. The National Technical Advisory Group on Immunization in India (NTAGI) makes 
decisions concerning new vaccine introduction and immunization program improvement with 
inputs from other technical advisory members from the MoHFW, technical partners and non-
profit organizations in the country (Chatterjee et al. 2016; Madhavi 2005).  
 
One of the earliest examples of decentralized vaccine delivery was the Government of 
India Act of 1919, which called for devolved roles of local self-governments (a three-tier local 
government structure at village, intermediate or block and district-levels which self 
administrates the area) with the responsibility to provide health services, including smallpox 
vaccination. This approach had mixed results on vaccine uptake because of lack of funds for 
vaccinators (Bhattacharya et al. 2006). Currently, vaccination is delivered through the 
community-level health structures such as: Primary Health Centers (PHC) and Sub-Centers (SC) 
at the administrative Blocks and villages, which are the lowest level of governance in the 
country (Bajpai et.al. 2005). Vaccination outreach among the communities is done by multiple 
frontline healthcare providers. They include auxiliary nurse midwives (ANM) who provide 
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comprehensive primary care, including immunization services, and who reside at the Sub-
Center of the designated catchment area; multi-purpose workers who live in the village and 
assist with vaccination delivery; Anganwadi workers (AWW); and community health workers 
(CHW). The latter two groups are responsible for mobilizing rural mothers to bring their 
children for vaccinations. Further, under the National Health Mission (NHM), there are 
Accredited Social Health Activists (ASHA) in the villages to encourage and facilitate full 




Thus, in this devolved, decentralized vaccine delivery system, a core element widely 
endorsed is ‘community engagement’ (CE) - an ill-defined term - delimited to informing 
communities about vaccines (like eradication of a vaccine preventable disease); or informing 
communities about vaccination schedules, and/or escorting community members by the 
frontline healthcare providers for vaccinations (Sharma, et al. 2014; Tedrow et al. 2011; 







Community Engagement (CE) in Vaccine Literature 
Both published and gray vaccine literature have emphasized the positive impact of 
community engagement (CE) in vaccination adoption and its utilization by the communities 
(Pramanik et al. 2018; Paterson et al., 2018). Global and country-level vaccine literature 
unanimously suggest early and ongoing CE for increased credibility of the 
informant/scientist/provider in the eyes of a potential adopter/user of vaccine, while also 
assisting the providers’ comprehend and respond to implementation realities, develop product 
ownership and user readiness among the communities, leading to better vaccine outcomes 
(Rogers 1995; Grayson et al. 1999; Poff et al. 2003; Cooperrider et al. 2003; Becker 2005; 
Newman 2011; Larson, 2015). While policymakers, researchers and program personnel are 
increasingly acknowledging CE’s virtue in vaccination utilization especially among the 
vulnerable populations, literature has critiqued on the varying levels of engagement perceived 
and practiced by decision-makers, and healthcare providers (Paterson et al. 2018.; Sarrami et 
al., 2014, Blanchard et al. 2013). 
 
Literature on vaccines and CE have used different theoretical frameworks. For example, 
the Health Belief Model analyzes community vaccination decision-making (Sturm et al., 2005), 
public trust framework examines trust on vaccines and provisioning authorities (Gopichandran 
2017), Social Network Framework addresses community’s vaccine confidence-gap (Wonodi et 
al. 2012, Larson 2011), Knowledge Translation and Education (Shea et.al. 2009) and/or 
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Continuum of CE (International Association for Public Participation, 2014) promotes and 
sustains vaccine uptake interventions. Again, firstly, these studies are limited, and second, they 
mostly address an aspect of vaccine demand generation by communities, without any 
elaboration of CE processes, which assumingly had led to increased vaccination (Carnegie et al., 
2017; Johri et al., 2015; Andersson et.al. 2009). 
 
Summarizing vaccine literature, CE has been conceptualized as community-based 
tailored interventions, targeted mostly for high-risk or vulnerable populations, and undertaken 
by government or implementation organizations (Tedrow et. al, 2012; Walters et al. 2000). CE 
involves providing communities with adequate information about vaccine benefits and access, 
and supporting all aspects of specific vaccines and vaccination services (Doctor Et al. 2012). To 
accomplish this, CE entails home visits by health workers or mass-media messaging (Blanchard. 
et al. 2013; Tedrow et al. 2011). The outcome of CE is to increase community demand for and 
use of immunization services. Some studies suggest that CE would eventually help communities 
identify and address their own needs for specific health services (Blanchard. et al. 2013; 
Blankenship et al., 2008), or enable community-led monitoring and advocacy to address these 
health needs (Newman, 2011; WHO Technical Report). In these literatures, the emphasis is on 
community empowerment, collective advocacy, and ultimately community control (Ross et al. 
2002; Bishop and Davis 2002). Again, some studies broadly define community/social 
mobilization as a downstream strategy to increase demand for or utilization of immunization 
services (Goldstein et al. 2015; Kochhar, et al. 2013). A recent evaluation in Ethiopia used CE as 
a strategy to implement a vaccine defaulter-tracing tool and a color-coded health calendar 
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(Paterson, Chantler, and Larson 2018). Again, a 2004 vaccine intervention study in Northern 
Nigeria explained CE as establishment of a network of thousands of community mobilizers who 
were engaged to increase awareness, understanding, acceptance and improve vaccine 
management of the polio vaccine after its boycott by the user community in 2003 (McArthur-
Lloyd, 2016). Pramanik and colleagues’ work in a state in India conduct randomized control 
trials whose results show that CE interventions addressed demand-side barriers while also 
mobilized the communities to advocate for better service delivery (Pramanik, et al., 2018). 
Again, in a previous study of African country plans for cervical cancer, ‘community/social 
mobilization’ mostly meant downstream efforts, which entailed community sensitization for 
cervical cancer prevention and control with very few plans conceptualizing it as involving and 
consulting the communities in the plan development processes (Dutta, Meyerson and Agley, 
2018). In all, there are various overlapping terms used to express CE such as community 
involvement, public involvement, patient participation, consumer and community engagement, 
community mobilization, social mobilization, shared decision making, distributed leadership 
(Sarrami-Foroushani et al., 2010; Gronn 2002; Florin and Dixon, 2004). Others have suggested a 
‘continuum of CE’ a progressive scale ranging from informing, consulting, involving, 
collaborating between government or organizations and the local communities, leading to 
empowering of these aforesaid communities (McArthur-Lloyd, et al. 2016; Bowen et al. 2010, 
Hart, 1997). Thus, even in this spectrum of conceptualizations of CE, ranging from government 
or other stakeholders giving information to the public regarding a particular service, to a 
genuine handovering of decision making power to the public, there seems to be an ambiguity in 
the definition and purpose of CE. Snape et.al.’s Delphi study found significant disagreement 
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between stakeholders on the purpose of CE in research as well as its justification on the 
grounds of ethics and patient empowerment (2014).  
 
Program literature and evaluation studies in India have mostly used terms like 
‘community sensitization’ when referring to CE-like concepts. This is defined as awareness of 
user-communities on the worth of immunization through community-based infotainment 
programs (Deutsch et al. 2017; Johri et al. 2015; Pandey, 2007). An infotainment or 
edutainment program is a knowledge change intervention combining education/information 
and entertainment. It is to be used in social venues, mostly measured as home visits by 
frontline healthcare workers. The purpose of these programs is to sensitize parents of infants, 
vaccine eligible adults, and communities about immunization for infants and pregnant women; 
follow up visits provided by ANMs, AWWs and CHWs to carry out first aid management of any 
minor side-effects resulting from the immunizations; other infotainment programs for vaccine 
awareness using mobile messaging and mass-media mechanisms; and occurrence of village 
council and Rogi Kalyan Samity translated as Patient Welfare Committee or village level 
Hospital Management Committee, meetings discussing any issues on immunization in the 
village (Adsul and Kar, 2013). Similarly, Lahariya et al.’s 2015 study conceptualized community 
mobilization as social marketing and other innovative communication strategies leading to 
increased vaccine utilization. Again, in these studies, there appears to be various 
understandings of ‘community sensitization’; but all convey the conceptualization that CE-like 
activities are a form of information transfer about vaccines from government to communities 
(Garwick and Auger 2003; Wallerstein and Duran 2010). Most Vaccine utilization studies in India 
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have concentrated on the challenges like communities’ lack of awareness (‘did not feel the 
need’, ‘not knowing about the need’ and ‘not knowing where to go for vaccination’ 
(Laxminarayan & Ganguly, 2011; Lahariya, 2015). Others have mentioned of myths and 
misconceptions on adverse events following immunization even when they might be unrelated 
to the vaccine (Bhatnagar et al., 2016) and mass-media and interpersonal communication 
impacting community’s sensitization for vaccines (Gopichandran, 2017, Laxminarayan & 
Ganguly, 2011; Lahariya, 2015). 
 
Most literature from India, as well as other developing countries, have either clearly 
expressed or implied one-way information transfer as CE-like activity, whereby the government 
and implementing organizations convey information to communities; rather than two-way 
participatory knowledge-flow (Perkin, 2009; Fraser, 2006). Evidence supports that this is 
occurring despite the fact that two-way knowledge flow facilitates capacity for critical thinking, 
decision making and action among communities (Dawson 2012).   
 
Existing studies have suggested that sustained utilization of vaccines as a function of 
user’s familiarity and knowledge of said technology, and credibility of the knowledge provider 
among the users (Steele 1989; Van Vliet and Gerber 1992). Studies from developing countries, 
where vaccine delivery is mostly decentralized like in India, suggest that groups and individuals 
in vaccine decision making positions should engage with communities early-on, during the 
planning stages of vaccine introduction, and sustain engagement throughout the 
implementation of vaccination programs to avoid vaccine implementation and acceptance 
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challenges (Paterson and Larson, 2012; Obregon and Waisbord, 2010). This suggests 
opportunities for two-way communication in CE. 
 
Further, studies of CE suggest paternalistic, top-down information catering, merely 
manipulating or informing communities, which has led to lack of empowered immunization 
decisions by communities, increased anxieties about vaccine safety among communities, lack of 
credibility among communities on the vaccine delivery system (Shetty et al., 2010; Poore et.al., 
1992) which in turn has resulted in lower vaccine uptake and in some cases even community-
based vaccination backlash (Larson, et al. 2016; Centre for Public Impact, 2017).  
 
Other key examples of knowledge flow are from the arena of coalition building like 
Himmelman’s work which differentiates between networking, coordinating, cooperation and 
collaboration, and echoes with the two-way knowledge transfer process that ‘collaboration’ is 
the highest engagement process of exchanging information for mutual benefit, sharing 
resources, and enhancing the capacity of another to achieve a common purpose (2001). In 
similar work by Mohr et al. (1994) there is emphasis on quality sharing and communication for 
participatory rather than vertical relationships. 
 
There is evidence that knowledge transfer interventions (whether conceptualized as CE 
or not), do not truly engage communities in an egalitarian way as they should be engaged. Li 
Hua’s 2003 study suggests that the disparate levels of technological advancement between 
conveyers of information and potential adopter lowers the chance of successful knowledge 
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transfer (2003). These differences have been conceptualized as a ‘two-community’ problem; 
meaning that socio-cultural differences between knowledge providers and users are barriers to 
engagement (Caplan, 1979; Cullen, 1990; Baskerville, 1997; Walters, 1998; Saywell and Cotton 
1999; Cullen et al. 2001; Kinzig 2001). Even when there is two-way communication, studies 
have suggested that differential power dynamics can serve to ‘co-opt and capture’ community 
input rather than accord them independent vitality (Head, 2007). Again, the study of African 
national cervical cancer prevention plans found a related concern of token involvement of 
communities, who were either referred to as ‘cancer survivors’ or ‘patients’ (Dutta, Meyerson, 
and Agley 2018).  
 
Such evidence has led to gradual shifting of emphasis away from a top-down approach 
to CE and towards building institutional bridges between governmental leaders and citizenry. In 
some cases, interest has focused on consultative CE to help develop vaccine policies (Vigoda 
2002; Lovan et al 2004; Kochhar et.al, 2013). Expressions of this shifts include the formation of 
advisory groups at the global level such as the Working Group for Vaccine Hesitancy under the 
WHO Strategic Advisory Group of Experts on Immunization (SAGE) (Dubé, et.al., 2014); and the 
Practice-based Research Networks of the Agency for Healthcare Research and Quality (AHRQ) 
(Wallerstein & Duran, 2010) which have been considered as CE. Similarly, whose second 
Strategic Objective by the Global Vaccine Action Plan (GVAP) expressed the belief that 
communities need to be more than passive recipients of immunization services (WHO, 2013). 
Further, there are recommendations that emphasize listening to community concerns, 
understanding public perceptions to inform risk communication, and incorporating community 
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perspectives in planning vaccine policies and programs (Larson and Watson, 2011). Similarly the 
Indian Academy of Pediatrics (IAP) mentions, “Involvement of community should be solicited” in 
their Recommendations for Vaccine Associated Paralytic Polio (IAP website) and the MI 
emphasizes to “generate awareness and demand for the immunization services through a much 
needed community-based communication strategy and social mobilization activities to enhance 
the participation of the community in the routine program of immunization through the mass-
media, mid-media, interpersonal communication and school, youth networks, and corporate” 
(Mission Indradhanush, Operational Guidelines, 2015). In 2001, The Vaccine Policy of India 
identified the need to conduct operational research to gauge the perceptions of the target 
community about immunizations towards developing community-responsive communication 
and advocacy strategy (Vaccine Policy of India, 2011). This conceptualization is more akin to 
market research to guide information flow.  
 
Thus, India’s need for a more engaged and dynamic conceptualization and practice of CE 
is warranted, given its substantial history of community backlash against different vaccines, 
primarily due to this top-down approach in vaccine planning and delivery. The earliest example 
occurred in 1850 over smallpox vaccine. Here, some Hindus resisted the smallpox vaccination 
because of religious incompatibility issues: the material used in cowpox vaccines was lymph 
from the cow. This was not acceptable, because cows are considered sacred by the Hindus 
(Bhattacharya et.al. 2006). In this example, Basu argues that this and the lack of tailored 
strategies to reach the hard-to-reach populations resulted in low smallpox vaccine uptake and 
coverage, with associated outbreaks reported even after five years of its roll out (Basu, 2006). 
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But this was likely not the result of strategic tailoring, per se, but a lack of initial CE about the 
strategy used in the first place. Basu and others arguing for strategy-tailoring issues are likely 
pointing to a more central issue of CE in the initial design of the strategy in the first place (Basu 
and Mittal, 2011).  
 
Vaccine uptake and acceptance issues have continued in the current era and are usually 
expressed post vaccine program implementation. For example, in 2010, the Government of 
India suspended HPV vaccination demonstration projects due to public concern about vaccine 
safety and conflicts of interest (Nigam 2014; Sarojini et.al, 2010). Community groups expressed 
concerns about pharmaco-governance, or pharmaceutical companies overreaching into the 
priorities of national governments, pushing vaccine onto an unsuspecting public (Larson & 
Watson, 2011). In the HPV case, it is not yet understood whether and how the government 
engaged communities prior to the implementation of the HPV pilot studies. It was argued at a 
press conference in 2010, that there was no engagement with the communities selected by the 
government and NGO implementers prior to pilot implementation (Larson et al., 2016; Bagla 
2013, Larkin, 2007).  
 
As recently as 2017, rumors shared via social media platforms of WhatsApp and 
Facebook fueled a mix of political conspiracy and safety concerns about the measles-rubella 
vaccine which brought down the immunization rates of otherwise better performing states like 
Tamil Nadu in India, by almost 10% (Sharma, Hindustan Times, January 2017). Here, however, 
Nichter and colleagues presumed an information-flow problem as examples of community’s 
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misinformation about vaccines, particularly among conservative Muslim and Hindu groups who 
linked immunization programs with hidden political agendas to selectively use anti-fertility 
agents among specific communities (1995). It may, however, be the case that here too, CE prior 
to vaccine program initiation could have informed information flow and programming. To my 
knowledge, no study has made this observation. 
 
Literature Gap in Understanding CE in the Vaccination Arena 
Notably, while the huge enthusiasm for CE through bi-directional knowledge sharing 
and transfer has been well expressed, there is a paucity of research about precisely what CE 
means, what engagement methods might be for effective knowledge-flow, and the necessary 
policy capacity to engage the communities. A key challenge to this is assuming a shared 
understanding of CE, which lacks a clear definition of what it is and how to measure it. Bell and 
Morse indicate that this might lead only to erroneous assumptions about its value, or lack 
thereof (2003). One of the major reasons for this literature gap could be because of the 
complexity in unbundling the concept of CE particularly in countries like India (Larson, 2011), as 
well as developing CE indicators (USAID, Health Communication Capacity Collaborative, 2017). 
Again, there are several unexplored areas when assessing the true nature of participatory 
governance, as to whether expressions of enhanced participation is due to the growing 
influence of the communities or whether these processes are largely the result of state-
directed outsourcing and state-controlled devolution (Foreman, 2002; Weber, 2003; Rhodes, 
2003). Many authors are also unclear of the robustness and independent strength of CE when it 
is largely at the discretion of the government and is largely shaped and subsidized by the latter 
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(Head and Ryan 2003; Head 2007). Despite these challenges, attempts must be made to 
advance the understanding of how best the communities are being engaged for vaccination 
uptake in India and what has been the mandates, resources and preparedness of the 





This dissertation research thus proposes to understand how vaccine decision-makers 
(individuals those with vaccine policy and programmatic decision-making positions at the 
national-level) - conceptualize CE and foster it. In addition, this research will identify the 
facilitators and barriers in implementing CE in the vaccine space of India.  
 
Research protocol was approved as Exempt by the Indiana University Institutional Review 
Board (IRB) (Protocol number 1710654732A001) (Appendix C).  
 
The study advances the following research aims:   
 
1. To examine and characterize the conceptualization of CE for vaccine introduction, uptake and 
adoption by national-level stakeholders with vaccine policy standing in India, particularly during 
2010 to current period encompassing the Decade of Vaccines.  
 
2. To explore barriers and enablers to community engagement for effective introduction and 
increased uptake of vaccines in India during the ‘Decade of Vaccines’ (2010-2020).  
 
These aims will help to identify opportunities and lead to future studies of how 
conceptualizations of CE affect vaccine confidence and uptake among the targeted 
communities in India. This dissertation will be significant for three reasons. First, while the 
rhetoric surrounding CE and participatory knowledge transfer is momentous, few studies have 
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drawn on preferences of those with a vaccine policy standing to adopt and advance CE 
(Brukardt, et al. 2004). Second, little research has been conducted to explore if there has been 
any transition from a paternalistic model to a consultative model of CE for vaccine introduction 
and its uptake during the Decade of Vaccines in India. Third, the study findings are time 
sensitive and will inform current CE strategies for new and emerging vaccines in India, to 
stimulate and sustain vaccination decisions, improve vaccine confidence and reduce the scope 
of vaccination backlash. These aims will help to identify opportunities and lead to future studies 
of how conceptualizations of CE affect vaccine confidence and uptake among the targeted 






As expressed earlier, this dissertation advances the following research aims:   
 
1. To identify and characterize the conceptualization of CE for vaccine introduction, uptake and 
adoption by national-level stakeholders with vaccine policy standing in India. 
 
2. To explore barriers and enablers to CE for effective introduction and increased uptake of 
vaccines in India during the ‘Decade of Vaccines’ (2010-2020). 
 
Study Design 
Examining the study aims was informed by Schutz's social phenomenology both as a 
philosophical framework and a methodology (2012), where interpretive research throughout 
the research process (Koch 1994) was used to demonstrate credibility or trustworthiness. A 
three-stage concurrent and sequential method of data gathering and qualitative analysis was 
used: (1) scoping archival review of vaccine policy documents, (2) key informant interviews with 
vaccine decision-makers in India, and (3) member check-in follow-up meetings with study 
participants and their teams (Figure 2). The study design allowed each concurrent stage to 
evolve and advance mutually from one another.  
 
Schutz's postulate of adequacy resonates with this interactive and iterative process of 
key informant interviews, document review and member check-in follow-up meetings. It helped 
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to validate and confirm findings with participants (Cutcliffe & McKenna, 2002). In addition, 
presentation made by the primary researcher (Dutta) of the initial data interpretation in the 
follow-up meetings ensured an accurate summary and some further recommendations by 
participants and their teams. This process allowed for consistency in the method though could 
not provide multiple interpretations and examples of CE postulated by decision-makers from 
different fields. When using this method for another study, the data coding could involve other 
themes being developed by experts from other fields (Sandelowski, 2002). 
 
[Figure 2]  
 
Rationale for this approach 
This multi-stage method facilitated understanding the vaccine decision-makers’ 
conceptualization and evolution of CE, advance continued search of vaccine policy documents, 
and facilitated exploring any new CE themes and categories like the identification of a CE 
spectrum rather than a dichotomous ‘no community engagement’ and ‘high community 
engagement’ (Van Maanen, 1979).  
 
For the purpose of this study, vaccine decision-makers are those people who hold 
positions of authority, which influenced policy development or implementation (plans, 
programs) from the national-level. 
Vaccine policy documents were included to provide an understanding of institutional 
orientation toward CE. Such documents will indicate whether there is evidence of CE’s 
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consideration, evidence of how existing CE priorities reflect leadership priorities, and provide 
insight into institutional conceptualizations of CE. 
 
Data Gathering 
Planning the Key Informant Interviews (KIIs) and Archival Document Reviews 
A semi-structured interview guide was used to facilitate the key informant interviews 
and archival document reviews. The guide was developed based on an interview protocol used 
by Project Muse which explored how public research universities are adopting a two-way 
interactive model of engagement on their campuses are the barriers and enablers that either 
inhibit or promote engagement in these institutions (Weerts, D. J., and Sandmann, 2008). 
 
Study guide sections included the following: (1) organizational conceptualization, 
policy, practice, history around CE including conceptualization of ‘community’ and 
‘engagement’, (2) organizational arrangement and resources for CE, (3) leadership support for 
CE, (4) coordination, capacity building and local partnerships to support and advance CE 
strategies, (5) barriers and facilitators of CE, and (6) CE and social mobilization delivery 
strategies, innovations and evidence building. The interview guide is in Appendix D.1. Initially it 
was planned that the duration of an interview would be 30 minutes.  
 
Review of vaccine policy documents 
A scoping review of the overall content of the vaccine policy documents was 
conducted, due to the diversity of the archival documents, broad scope of CE, limited time, 
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and no earlier national-level review on this topic (Arksey, 2005). The work was guided by 
scoping reviews done by Thulien (2014) and Williams-Brennan et al. (2012). Thulien conducted 
scoping review to determine gaps in current knowledge on cervical cancer screening for sex 
trade workers. Williams-Brennan and colleagues analyzed interaction among different social 
determinants of health and their impact on cervical screening among women in low and 
middle-income countries. This dissertation also referred to the African Palliative Care 
Association’s (APCA) scoping review on palliative care policy development in each African 
country (Rhee et al., 2014). Elements in these studies resonated with this study because these 
were conducted at the national or continental-levels, entailed reviewing diverse gray 
literature, analyzed aspects (like cervical screening) which, though aspired by policymakers 
were compromised given the resource constraints and health governance related issues of 
Africa. However, typical of biomedical and epidemiological research, these studies explored 
single socio-demographic variables affecting cervical cancer screening, whereas this 
dissertation research has identified CE at all levels of Social Ecological Framework and has 
additionally proposed intersectionality approach for a richer understanding of CE.  
 
Inclusion, Recruitment, and Conduct of KIIs  
For the vaccine policy documents, initial Boolean internet search was conducted 
between November and December 2017 using words like ‘vaccine’ AND ‘policy’ OR ’guideline’ 
AND ‘India’ which helped to identify 20 policy documents. Thereafter when the study aims 
were shared with the abovementioned study participants, they recommended more 
documents, which were added to the list. All the documents were available online in the 
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website of Ministry of Health and Family Welfare (MoHFW), Immunization Technical Support 
Unit (ITSU), National Technical Advisory Group on Immunization (NTAGI), country offices of the 
World Health Organization (WHO), United Nations International Children’s Emergency Fund 
(UNICEF), and CORE Group Polio Project (CGPP). In most cases, the Communication personnel 
helped the researcher with the links or provided a hard copy of the policy documents. Twenty-
four vaccine policy documents in English language, which were available online were included 
in this study and were reviewed. 
 
Vaccine decision-makers were purposively selected for their policy and program 
management experience and an initial list of 30 potential participants was created. Because of 
the position of authority, along with their publicly available contact information, identification 
of the vaccine decision-makers was not too difficult. Twenty-eight participants were selected 
through snowballing process based on informal discussions and networking by me. 
Approaching them became comparatively easier because of my earlier work on CE with some of 
these vaccine decision-makers in India. Two had to be excluded from the list because one did 
not have a physical office in India, and another could not be contacted. First, an email was sent 
to all the 28 decision-makers in December 2017 explaining the study information and 
requesting an invitation for an interview (Sample of the email highlighting study purpose and 
requesting study participations can be found in Appendix D.2). In case of no responses from the 
study respondents or their office, the first follow up emails were sent in early January 2018 
after around ten working days. In most cases, once the decision-maker consented via email to 
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participate in the study, follow up phone calls and emails were sent to their offices requesting 
an interview date between 12-15 days after the initial invitation.  
 
For most respondents two emails followed by a call yielded response. However, for 
representatives at the Ministry, initial email by me, followed by an introductory/reference 
phone call by another contemporary in the Government/donor/technical organization 
facilitated accessing the potential interview participants and recruiting them. Twenty-five 
vaccine decision-makers participated in the one-on-one interviews. Follow up calls were made 
to their offices to finalize on the interview date. Due to the ongoing Winter session of the 
Indian Parliament then, the media critiquing regarding the pilot of HPV vaccines, and the 
rollout of measles-rubella (M-R) vaccines, most of the decision-makers were very busy (Rao 
and Govindarajan; Feb 2017; Khan, May, 2016; Jayachandran and Raman, August 2018). Thus, 
it would often take more flexibility of time on the lead researcher’s (Dutta) part to finalize the 
interviews, at times conducting them at unconventional times, like early mornings or on 
national holidays. In addition, politicized sensitivities had to be acknowledged and caution was 
exercised while tailoring questions on aspects like ‘CE and preparedness for HPV vaccine 
introduction in India?’ Details of the process of inclusion of study participants and vaccine 
policy documents is explained in Figure 3.  
 
[Figure 3]  
 
25 
The key informant interviews were conducted by Dutta in-person during December 
2017 to February 2018. All the interviews were conducted in English, in the offices of the 
decision-makers. The offices of these decision-makers were located in New Delhi the national 
capital of India or the National Capital Region, which constitutes of places around the city of 
New Delhi. The interviews lasted approximately 45 minutes to an hour. Verbal informed 
consent was obtained from all participants prior to conducting and recording the interviews. 
 
Conducting convening follow up meetings 
The study also involved convening participants as a group in December 2018 to verify 
the findings from the key informant interviews. This was decided because it would give a 
chance to confirm the completeness of archives included and seek clarifications from 
interviews, if any. The plan was to conduct further review and analysis based on the outcomes 
of this meeting. Emails requesting for this meeting were sent to all the participants during the 
first week of December 2018. Except one person at the Ministry, and another heading a multi-
partner project, all the participants expressed keenness and participated in the convening 
meeting. Additionally, participants from the technical bodies of the Ministry, NGOs, and donor 
organizations, invited other colleagues of their organization or Department to join in the 
discussion. Three participants who could not be present during the convening meeting invited 
Dutta for one-on-one meetings at their respective offices during January 2019. 
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Theoretical Framework and Measurement  
This study is guided by the hybrid conceptual frameworks of Knowledge Flow Theory 
(KFT) (Weerts, 2007a, 2007b) and the Social Ecological Model (SEM), to explore the framing and 
fostering of CE by those having a vaccine policy standing in India.  
 
It was initially anticipated that the realms of CE measurement in the KFT framework 
(Carnegie Community Engagement Classification) would guide tailoring CE categories in the 
study. The Holland Matrix of the KFT provides a structured framework for an academic 
institution to assess its 'state of preparedness' for engagement and interaction with 
communities. The matrix offers a framework for measuring university capacity and 
preparedness to 'engage' with communities in shared work that is of mutual benefit 
(contributes to teaching, learning and research outcomes, while also collaborating with external 
communities seeking improvement in community outcomes) (Holland, 2001). Partnership and 
reciprocity are key aspects of this form of CE. The instrument asks applicants to describe how 
they seek feedback from communities on several levels. 
 
Examples of questions in the KFT framework were:  
(1) ‘Does the executive leadership of the institution explicitly promote community engagement 
as a priority?’  
(2) ‘Does the institution have a campus-wide coordinating infrastructure to support and 
advance community engagement?’  
(3) ‘Is community engagement defined and planned for in the strategic plans of the institution?’  
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An example of the KFT themes is cited in Table 1. 
 
[Table 1]  
 
The hypothesis of KFT is that, knowledge creation, such as in the case of vaccine policy 
or programing, is an evolving process and occurs in the context of a community. CE and 
community-level collaborations, are thus both, knowledge building processes and a 
developmental outcome, which emerges from a series of ongoing, informal and formal 
relationships between the communities and the policy-level decision-makers (Håkansson, 1990; 
Von Hippel, 1988). KFT challenges knowledge hierarchies, such as expressed through top-down 
vaccine policy or programming, and reflects the work of Nyamnjoh who considers everyday life 
of social spaces as bona fide research sites [which] entail, ‘taking the popular, the historical and 
the ethnographic seriously, and emphasizing interdependence and conviviality’ (Nyamnjoh, 
2015).   
 
A challenge was that there is limited work using KFT, and as such, required 
primary reliance on work by Hutchinson & Huberman (1993), National Center for the 
Dissemination of Disability Research, (1996), Weerts, and Sandmann (2008). These 
studies using KFT have focused on the ‘knowledge flow space’ and its ‘directionality’ in 
higher education academic settings studying academic-community partnerships to 
distinguish between one-way or top-down versus two-way or bi-directional knowledge 
transfer approaches (Weerts, 2007a, 2007b). By understanding this directionality of 
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knowledge, KFT helps to understand whether community engagement has been 
participatory versus top-down and identifies barriers to build productive relationships 
between universities and other external stakeholders like community partners. Using 
knowledge flow as a key aspect of CE means reciprocity in interaction and knowledge 
transactions between communities and the government; local partnerships acting as a 
sounding board to the government in sharing community’s vaccine concerns; and 
participating in vaccine planning.  
 
This dissertation followed the philosophy of several reformist and developmental 
orientations to reiterate the critical importance of bi-directional knowledge sharing and co-
learning as opposed to unidirectional flow of knowledge in vaccine policies and programs in 
India, the latter being termed as ‘bad outreach’ by some authors (Zandvliet and Anderson, 
2009). For instance, seminal work by Foucault has already provided a theoretical grounding on 
the intrinsic interconnectivity of knowledge and power, and how knowledge is produced within 
power relations which influences the broader discourses and that the power-relations of 
discourses are deterministic to what will be known (Ball, 2013; Foucault, 1980; Dimitriadis, 
2006). This is close to Ostrom’s work who proposed ‘knowledge co-production’ as between 
decision-makers and the communities (1996).  
 
It was ideated that the Holland Matrix of KFT will measure institutional intent in bi-
directional knowledge transfer. This matrix has been used in other KFT studies, though not very 
widely, and measures CE as the collaboration between institutions of higher education and 
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their larger communities (local, regional/state, national, global) for the mutually beneficial 
exchange of knowledge and resources in a context of partnership and reciprocity (Carnegie 
Foundation for Advancement of Teaching, 2006; Holland 2001).  
 
Initially though KFT was chosen, due to the inherent limitations of the matrix in looking 
at ‘vaccine decision-makers and ‘communities’ as conglomerate wholes, interacting in two-way 
top-down or bottom-up communication, SEM model was laid. The lens of knowledge transfer 
was used to analyze CE and vaccine related knowledge transaction. The evolution of the use of 
the theoretical framework is explained in the following sections.  
 
Limitations in the Knowledge Flow Theoretical (KFT) Framework  
This study focused on a different sense of CE as compared with the KFT framework. The 
KFT’s definition focused on institutions and their relationship with various publics, whereas the 
conceptualization of CE involved in this dissertation entailed decision-makers’ engagement of 
community members as self-determining actors in ways that led their own understanding and 
uptake of strategies and actions to improve their vaccination decisions. In this context, there is 
a subtle but important distinction between these two views of CE. In the Holland Matrix the 
interaction between university and community was more one-way rather than reciprocal, 
though it was not very clear. 
 
For example, Zhuge (2006a. 2002) defined Knowledge Flow as sharing and 
processing of knowledge among individuals; differing based on the direction, content 
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and carrier of the knowledge. Here, the assumption is that knowledge is diffused from 
those who are positioned ‘higher’ than the community such as formal authorities. 
Some Knowledge Flow theorists also suggest partnerships through ‘Knowledge Nodes’, 
which is a single persons or groups who begin a learning path starting from a specialty 
– whether functional specialization, specialization of product, of process, that are 
linked by some kind of complementarity, so as there are opportunities to generate 
value by exchanging or pooling inputs between the senders and the recipients (Zhuge, 
2002; Zhuge, 2006b). Here, the flow of knowledge is identified either resulting from a 
trigger of a source which is known as push strategy or a knowledge request made by 
the recipient, known as the pull strategy (Jarrahi and Kangavari, 2012; Zhuge, 2006a). In 
this case, there is an unsubstantiated assumption that biomedical knowledge, once 
reached and reinterpreted by the communities will be appropriated and accepted by 
the community and become part of the local belief system (Geissler & Pool, 2006). 
 
The belief was that this framework and related philosophy overlooks the possibility that 
knowledge may also be in conflict with the traditional existing knowledge of the community 
(Bisht & Coutinho, 2000; Bastien 1995). In the case of immunization, as earlier studies have 
highlighted, even when communities come to accept vaccination, they do not necessarily do so 
with the biomedical understanding of vaccines and immunity they provide (Bisht & Coutinho, 
2000). Also, knowledge exists at many levels in organizations, and with the increasingly online 
sharing mechanisms (Hara, Shachaf, & Hew, 2010) there are increasing tendencies among 
communities not to rely on experts to gain scientific knowledge (Hara and Sanfilippo, 2015). 
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The approach also seemed ill-equipped to address the plethora of political, social and economic 
conditions and grounds for social resistance to repetitive top-down information sharing for 
immunization.  
 
Laying CE and KFT in the Socio-Ecological Model (SEM)  
Following this line, it was decided that the existing ready-to-use KFT might be an 
over-simplistic depiction of analyzing the tenets of CE in the vaccine arena, whose 
inquiry involves complicated, and multiplicity of interacting factors. Therefore, a hybrid 
of KFT and Socio-Ecological Model (SEM) adapted to analyze differential power 
between those communicating and those receiving information was used. This seemed 
the most appropriate because, community engagement is a complex process, 
expressed at multiple levels, and entails behavior change interventions, establishment 
and maintenance of partnerships among diverse community groups, which perhaps is 
encoded in policy (e.g., educational, regulatory, economic). 
 
 The SEM has been used extensively in the field in health promotion, both as a tool to 
elucidate its etiology, as well as developing interventions, and measuring their efficacy. One 
theoretical basis for SEM is visualizing individuals and communities in concentric layers, where 
individuals are embedded within communities, communities form social networks, which in 
turn are within institutions, and are impacted by policies (Kumar, et al. 2012). Stokols and 
colleagues argued that it is the interventions at multiple social ecological levels because that 
leverages contextual and cultural knowledge, practices, and resources of all individuals and 
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organizations involved, while also contributing to sustainability of the interventions (1996). 
McElfish et al. perceived SEM as a facilitating tool to allow interventions at distal contextual 
levels that target across multiple levels simultaneously to leverage both, environmental and 
behavioral effects (2016). The social ecological paradigm for health promotion extends these 
notions by providing a set of conceptual and methodological principles, drawn largely from 
systems theory advocating for interventions at different levels for widespread influence 
(Stokols, 2000).  
 
 The vaccine and SEM literature have expressed communities’ vaccine decision-making 
as a function of their perception of individual risk, the prevalence of vaccine uptake in their 
area, their perceptions of susceptibility of contracting the disease, as well as if they are 
encouraged to get the vaccine by their healthcare providers, and whether federal healthcare 
policies favor their access to affordable vaccines (Kolff, 2018; Nambe, Hal and Kamden, 2016; 
Kumar, et al. 2012). In his work Kumar et al. used SEM to demonstrate that factors on all levels 
of the SEM influenced whether communities received the H1N1 influenza vaccine and 
recommended interventions targeting multiple levels than targeting specific levels. Similarly, 
UNICEF Communication for Development (C4D) supports combination of interventions at all 
levels and corresponding C4D approaches for every SEM level like: Behavior change 
communication, social mobilization (including strengthening an enabling media and 
communication), and social change communication and advocacy that produces program 
synergies for positive change within a social system (UNICEF, (C4D)). Other spheres of 
biomedical prevention, like the North Carolina Breast Cancer Screening Program collected 
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process data about environmental, organizational, program and individual characteristics 
(Viadro et al., 1997). CDC uses SEM by identifying high-impact ‘leverage points’ in resource-
limited settings noting that multi-level systems approach using combination of interventions at 
all levels optimizes resources and likely has a higher chance of success (Proctor et al. 2004).  
 
While SEM has been extensively used, there is limited evidence assessing the 
distribution of CE interventions leading to vaccination and health benefits by socio-economic 
strata. This becomes more critical in the context that GVAP lists equity as one of its six guiding 
principles (Brearley et al., 2013). This study does this with a paradigm shift, away from studying 
focused interventions aimed primarily at changing individuals’ health behavior, to more 
comprehensive ecological aspects of CE, which examines the interdependencies between, 
political, organizational, community, and individual-levels. This, to some extent is able to 
address what Burke et al. have pointed out as ‘reciprocal determinism’ between various levels 
of the SEM impacting behavior which may involve interactions between levels over time (2009). 
The study while indicating engagement efforts being carried out at various levels, also hopes to 
highlight any particular conjunction of interventions at the interpersonal, institutional, 
organizational, community, and policy levels which were found to be most effective.  
 
 Further, there seems to be a tendency of failing to apply the whole SEM model 
consistently in the whole ecological canvas of CE, and a rather narrowly concentrating at 
vaccination uptake, or a particular intervention. We argue that the SEM can be a useful 
analytical platform to examine CE across all populations, assess enablers and barriers of CE at 
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each level, and how interaction occurs between levels, which may help improve the impact of 
interventions, and vaccination uptake. This will help to clarify and assess the magnitude of CE 
factors for immunization and enable recommending policies and programs to address them in 
the current setting.  
 
 That said, vaccination decisions are shaped by past experience such as witnessing side 
effects or bearing any misunderstanding regarding vaccinations based on the collective memory 
of their group heard over the life span, rather than one’s own perception and characteristics. A 
limitation of using this theoretical framework is that while it adds to the one-dimensional 
continuum (from minimal involvement to active engagement), and the two-dimensional 
vaccine information flow process between communities and the authorities, it has not analyzed 
CE in a three-dimensional perspective of engagement processes, knowledge co-production, and 
time.  
 
The Social Ecological Model (SEM) conceptualizes that individuals’ vaccination outcomes 
is influenced by the dynamic policy, community, organizational, interpersonal, and individual 
factors (Kumar et al., 2012; Kolff et al., 2018; Nambe, Hal and Kamden, 2016; Baral et al., 2013). 
For example, the policy-level factors includes policies and regulations affecting communities 
and the institutions, the community-level factors are incumbent of the relationship among 
different institutions within communities, the organizational-level factors constitutes 
institutional organization and management, the interpersonal-level factors include interactions 
of individuals with families, peers, neighbors, and healthcare workers  and the individual-level 
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factors include vaccine related beliefs, values, and other individual factors (Crosby, Salazar, & 
Decremented, 2013; Oku, 2016; Spiegel 2005). Considering that the SEM theory has been 
earlier used to understand vaccination uptake (Kumar, 2012; Nambe, Hal, & Kamden, 2016), a 
deductive approach was used to identify recurring and emerging themes (Hsieh et al. 2005; Elo 
and Kyngäs 2008).  
 
Measurements  
Data from interviews, archival documents and field notes were categorized by SEM 
levels as follows (Table 2):  
 
(1) Policy-level factors include written evidence of CE in policies, strategic plans, 
regulations, and mention of incorporation of CE in vaccination campaigns, examples of political 
will ensuring resources for CE or incorporation of CE during disease outbreaks, which 
influenced positive vaccination decision among communities. 
 
(2) Community-level factors include power-structures in the society like structural barriers 
related to class, caste, gender, rural versus urban divide, and community’s lack of trust 
expressed in incidents where communities have negotiated, bargained and/or strategized with 
the vaccine providing people/organization – like ‘build the road then we will take the vaccines’ 
or critically questioned the intent of the vaccinators like ‘what must be the plot of the 
Government to vaccinate’, which has affected communities’ trust on the vaccination providing 
systems and thus impacted the vaccination rates. 
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(3) Organizational-level factors means formal or informal partnerships between national 
and local stakeholders like religious leaders, clubs like Rotary and Lions, women's self-help 
groups, youth groups like NSS, NCC, NYK, who undergo training by the MoHFW, UNICEF and 
WHO, and in turn, as local champions influence positive vaccination decision among 
communities. Engagement with these local role models or vaccine champions is distinctly 
different from celebrity engagement, which is vaccination sensitization of communities 
through mass-media done by a famous personality. 
 
(4) Interpersonal-level factors included issues around Inter Personal Communication (IPC) 
and Social Behavior Change Communication (SBCC) on which healthcare workers are trained to 
thereafter counsel communities for vaccination.  
 
(5) Individual-factors consisted of any examples of direct communication between 
decision-makers and communities addressing vaccine concerns reflecting the latter’s belief 
and perspectives of meaningfully engaging with communities which affected community’s 
decision to vaccinate themselves or their children. It also includes management of vaccine 
related myths, rumors, and misinformation among communities by decision-makers.  
 





First, all the interviews were audio taped and transcribed verbatim by me after 
excluding “ums” and “ahs.” Researcher field notes taken during both, the archival document 
review and during the process of interview, and convening meetings and were included as a 
memo to the respective interviews or meetings. Field notes were based on the manifested and 
latent expressions of the study participants and helped my interpretive analysis that is 
concerned with the response as well as what may have been inferred or implied during the 
interview. Based on the transcribed raw data collected on the CE focal areas, and my field 
notes, a chronological meaning making was done describing how the CE component came 
about, key collaborators who were/are involved, and the major milestones. Study participants 
were requested to review their transcribed files, but due to lack of time the summary with the 
respective participants had to be reconfirmed. 
 
An a priori deductive framework, which complemented the research questions by 
allowing the CE tenets to be integral to the process of organizing text for a deductive thematic 
analysis while allowing themes to emerge direct from the data (Fereday and Muir-Cochrane 
2006). It helped develop the coding constructs that defined the components as well as barriers 
and facilitators of CE. Thereafter, two researchers and I reviewed five transcribed interviews 
and two policy documents independently in November 2017 and coded these. Inter-coder 
reliability (Kappa) was established with >90% consensus among raters through repeated 
readings and re-readings of the interviews and documents and consensus meeting discussions. 
This was an iterative procedure (Glaser and Strauss, 2017) that involved moving between the 
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summaries, existing theory, and the interview data, particularly during the integration of the 
interview data with the archival documents. The concepts identified were reintegrated into 
themes, which provided the structure for the results. This led to a form of pattern recognition, 
with emerging themes/nodes becoming the categories for analysis (Fereday and Muir-
Cochrane, 2006). For example, the study characterized different CE to the extent to which they 
might have generated new practices, strengthened adoption of vaccines or built sustainable 
and distinctive capacities. Thereafter, these categories were refined by tracing patterns and 
consistencies (Mintzberg, 1979): the interviews were scrutinized and initial ideas elaborated as 
additional evidence. The analysis continued with this interplay between the data and the 
emerging patterns until the patterns were refined into adequate conceptual categories (Bailyn, 
1977; Eisenhardt, 1989).  
 
The final coding instrument consisted of seven themes and 42 sub codes (Table 3). This 
final coding instrument was used to code the data of the interviews and policy documents. 
NVivo 12 (QSR International, Melbourne, Australia) software was used for line-by-line, open 
and axial coding, with openness to new themes that emerged.  
 
The first step was to analyze each interview and policy document to identify key CE 
fostering mechanisms and barriers. Thereafter CE enablers and barriers for vaccination were 
classified into all the SEM levels: policy-level, community-level, organizational-level, 
interpersonal-level, and individual-level factors and reported as exemplar quotes from 
interviews and content of the policy documents. Constant comparison was used to highlight 
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similarities and/or differences between aspects of CE mentioned during the interviews but not 
in the policy documents or vice versa. Finally, the transcribed data from the archival review, 
analyzed interviews, and field notes were triangulated for validation, address completeness, 
convergence, and dissonance of key themes. 
 
[Table 3]  
 
Restatement /Clarity about the Methods Used for the Following ‘Findings’ Chapters 
The first findings chapter (Chapter 4 in this dissertation) of my thesis titled ‘Vaccine decision-
makers’ conceptualization and fostering of community engagement in India’ explores how 
vaccine decision-makers at the national-level in India conceptualize CE, the evolution of CE in 
the vaccine arena in India, and their individual and/or institutional support to foster CE, 
especially during the Decade of Vaccines (2010-2020). This paper is based on the findings from 
the elite interviews of the vaccine decision-makers in India. For this paper, content analysis of 
the interviews was undertaken to identify experiences, evolution, and fostering of CE. This 
research followed a naturalistic ontology model and allowed to grow from the epistemology 
and methodology of the process (Lincoln and Guba, 1986). Though the focus was to analyze CE 
during the Decade of Vaccines (2010-2020), examples of social mobilization during the National 
Polio Surveillance Program (NPSP), in the late 90s and introduction of the Japanese Encephalitis 
vaccine in 2006 were critical because they had a bearing with the evolution of CE, and have 
thus been considered in this research.  
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The second findings chapter (Chapter 5 in this dissertation) analyzes community 
engagement barriers and enablers for vaccination in India. The results from the policy 
documents review, elite interviews with the decision-makers, and convening meetings 
were triangulated to identify enablers and barriers to CE for vaccinations in India were 
triangulated to report the findings. Results are reported using the philosophy of KFT 




This chapter highlights the steps involved and demonstrates the rigor in conducting a 
staged qualitative research study. Outlined is a detailed method of analysis using a process of 
thematic coding that involves a deductive coding (derived from the philosophical framework) 
and identifying themes emerging from participant's discussions. This careful description of the 
steps and processes used in data analysis can be replicated and assist other researchers in 





VACCINE DECISION-MAKERS’ CONCEPTUALIZATION AND FOSTERING OF COMMUNITY 
ENGAGEMENT IN INDIA 
Abstract 
 
Introduction: India has made tremendous progress during the Decade of Vaccines (2010-2020) 
by introducing multiple new vaccines, along with strategic interventions like the Mission 
Indradhanush, and decentralized community-based vaccination delivery to ensure 90% 
immunization rates. Despite this progress, unmet vaccination need is very high in the country, 
leading to the death of around 500,000 children annually, and to the emergence of clusters of 
unvaccinated children in which disease outbreaks can occur. Existing evidence showcases lack 
of appropriate community engagement (CE) as a central tenet for vaccine resistance and 
backlash by communities leading to lower vaccination uptake. However, the current evidence-
base neither has a consensus on CE nor is clear about its effectiveness. This study examines 
conceptualization, evolution, and fostering of CE in India from 2010 to the present times by 
vaccine decision-makers in the country. 
 
Methods: This qualitative study was undertaken from December 2017 to February 2018. 
‘Studying-up’ method was carried out by interviewing 25 national-level vaccine decision-
makers. Study participants included policymakers, immunization program heads, and heads of 
vaccine technical committees from the Government, international agencies, donors, and non-
profits. Data analysis was done using key CE themes.   
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Findings: The study identified a broad spectrum of communities and CE, rather than linear 
utilitarian-empowerment dichotomy. Decision-makers conceptualized ‘communities’ as 
vaccine-eligible children and their parents and vaccination influencers, like local-level 
healthcare providers, religious leaders, NGOs, and CBO members. CE was variously defined as 
community outreach, capacity-building, and information dissemination for vaccination. There 
was no explicit policy guideline defining CE or CE activities, especially for contested vaccines, or 
monitoring and evaluation related to CE. CE evolution was explicitly noted, from house-to-
house polio campaigns to targeted information dissemination among vaccine resistant 
communities, and intensified capacity-building during the introduction of recent vaccines. 
Participants recommended developing an operational definition of CE in the vaccine space, 
codifying it in policy guideline documents, documenting CE best-practices, planning CE from the 
vaccine initiations stages, and developing a better understanding of communities’ trust of 
vaccine delivery systems and policies.  
 
Conclusions: The study recommends analyzing CE in the context and history of the social 
construction of vaccines among communities. Broader conceptualization of CE is needed, 








Decision-makers in biomedical prevention research and practice are increasingly 
recognizing the virtues of community engagement (CE) because it improves research efficiency, 
dissemination, uptake, implementation of research findings, and public perception of 
biomedical prevention, while decreasing the likelihood of therapeutic misconception and 
facilitating constitution of multi-sectoral coalitions (Fregonese, 2018; Tucker and Rennie, 2014). 
This has led to what some term the ‘governmentalization' of CE which refers to the 
governmental embrace of CE, expressed by a sustained political will to integrate CE, in 
biomedical policies and programs, balancing technical and lay expertise, and engaging in a 
respectful, dynamic relationship with the community (Tindana, 2007; Carlisle, 2010; Crawshaw 
et al., 2003). This governmentalization of CE has invigorated the social values in government to 
facilitate technology transfer while empowering communities to make informed choices for 
biomedical prevention tools like vaccines (Milstien and Kaddar, 2006; Folayan, et al., 2015; 
Boxelaar et al., 2005; Kilpatrick, 2005; Carlisle, 2007; King and Cruickshank, 2010; Gaventa, 
2004).  
 
In India, governmentalization of CE in the vaccine space is mostly evident through 
federal investments by the government, and donated investments and contributions by trusts 
and foundations respectively, to strengthen routine immunization, especially in pockets of high 
vaccine resistance and low vaccination coverage (Griffith et al., 2011). Despite these 
investments and the interventions thereof, the latest national survey shows that only 62% of 
children (12-23 months) received all basic vaccinations (protecting against tuberculosis, 
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diphtheria, pertussis (whooping cough), tetanus, polio vaccine, and measles); and 63% percent 
received all the three doses of Hepatitis B vaccine (National Family Health Survey, 2017, 
Madhavi, et.al., 2005). These rates are much lower than the national targets, and progress still 
remains too slow for most immunization goals to be reached by the end of the Decade of 
Vaccines in 2020 (GVAP, 2017). This has resulted in huge vaccine unmet need leading to high 
vaccine-preventable morbidity and the death of around 500,000 children every year in the 
country (Tandon, May 2018). Public health researchers attribute this low immunization uptake 
to poor community participation and to community skepticism about the Government of India’s 
(GoI) intentions for the Universal Immunization Program (UIP) (Vashishtha and Kumar, 2013).  
 
Evidence of community skepticism and lack of vaccine support has been extensive and is 
seen in recurring incidents of vaccine resistance and backlash by communities such as covert to 
overt vaccine resistance ranging from people closing their doors and windows when they hear 
vaccinators approaching, to physical strife between vaccinators and communities (Larson et al., 
2011). The cervical cancer-preventing human papilloma virus (HPV) vaccine’s post-licensure 
trials, arguably the demonstration projects, resulted in negative public opinion and suspension 
of the vaccine introduction by the Supreme Court of India in 2010 due to adverse events and 
lack of CE procedures (Bagcchi, 2013). Even after the January 2018 approval of the vaccine by 
the NTAGI, the national government’s advisory body and highest technical agency that 
recommends vaccines, the country's right-wing groups wrote letters urging the Prime Minister 
to stop any attempt to pilot the vaccine. This and prior community challenges to HPV vaccine 
resulted in a staggered vaccine launches only in Sikkim State, and pilots in Punjab and Delhi 
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States (Gangtok, Northeast Now, July 26, 2018; Prasad, The Hindu, October 4, 2017; Sputnik, 
June 2017; Belani, 2014; Bagla, 2013; Shetty, 2010). This is not only an issue for the HPV 
vaccine. In 2010, Public Interest Litigation prevented the introduction of pentavalent vaccine 
protecting from meningitis, pneumonia, otitis, whooping cough, tetanus, hepatitis B and 
diphtheria (Nair et al., 2011). Rao and Govindarajan reported decreased uptake of measles-
rubella vaccination in certain states of India amidst social media rumors of political conspiracy 
for unsafe vaccinations (Scroll.in, Rao and Govindarajan, June 2017; Hindustan Times, Sharma, 
January, 2017).   
 
In response to these incidents, there has been a growing sensitization among decision-
makers in India, a group which includes policy-level people, program heads or associates, and 
vaccine decision-makers of the government, private sector, NGOs, and international agencies at 
the national-level, regarding the importance of engaging communities in the development, and 
eventual dissemination of vaccines and other biomedical strategies. This was particularly 
evident after the Supreme Court recommended meaningful dialogue with the community for 
vaccines and regionally- appropriate immunization strategies to help accelerate vaccination 
(Rao and Gopichandran, 2017; Goldstein et al., 2015; Laxminarayan and Ganguly, 2011; 
Madhivanan et al., 2014; Obregón et al., 2010). As yet, however, it is not precisely clear what is 
happening in terms of the country’s efforts to engage the communities for vaccine support and 
uptake (Sengupta et al.; 2011).  
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The first step toward understanding any activity related to CE and its impact on vaccine 
uptake is to define and characterize CE and the efforts taken by the national government and 
vaccine decision-makers in ‘doing’ CE. Existing studies highlight ethical, political, relational, and 
public health imperatives of CE for vaccine acceptability in a historical context of colonialism, 
exploitation and marginalization (King, 2010; Hunter, 1995; Ostrander, 1995; Brukardt, 2004, 
Patel and Nowalk, 2010). Macqueen et al. have identified CE’s varied definitions and absence of 
CE metrics (2015). The lack of measures is likely an outcome of difficulties conceptualizing CE or 
actualizing effective CE (Mcqueen, 2009; Leon et al., 2015). Thus, understanding CE in 
vaccination efforts should include the perspectives of vaccine decision-makers. Prior studies 
have not done so.    
 
This study explores how national-level vaccine decision-makers in India conceptualize 
CE, the evolution of this conceptualization, and individual and institutional support for CE 
during the Decade of Vaccines (2010-2020) in India. Study findings will inform vaccine decision-
makers of the prevailing views of CE, issues and data needs related to CE, and may trigger a 
policy dialogue regarding these issues. This study is timely, as the GoI is introducing several 
vaccines in its immunization program, which, in addition of being contested or feared by the 
communities, are often considerably more expensive than existing vaccines, and target diseases 
which are relatively ‘hidden’. Therefore, broadening the understanding about these issues will 
respond to Greenwood’s call for a concerted and strategic CE for empowered vaccine decisions, 
establish why CE will facilitate communities’ vaccine adoption, and finally recommend CE 
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strategies that will enable effective uptake of all vaccines among the vaccine eligible 
populations (Enria et al., 2016).  
 
Methods  
Study approach  
This exploratory study was conducted in India among vaccine policy decision-makers. 
Synthesizing the work of Angwenyi (2014), Larson et al. (2011), Gikonyo (2008), and Cvetkovich 
et al., (2002), the authors in this study define CE as: (1) an upstream policy imperative, rather 
than  downstream interventions ‘for the community,’ (2) incumbent to sustained political-will 
for community-sensitive, evidence-informed, tailored vaccine policies and programs, (3) 
providing equitable and tangible vaccination, transparent communication, and capacity building 
benefits (4) enabling communities’ empowered agency to critically analyze vaccine-related 
myths and misinformation for vaccination decisions, and (5) bringing in nuanced community 
aspects influencing policy recommendations while building trustworthy relationships between 
vaccine decision-makers and communities.   
 
Inclusion Criterion  
During December 2017 to February 2018, key informant interviews (KIIs) were 
conducted with a purposefully selected sample of 25 country-level immunization leaders and 
decision-makers in India to assess their conceptualization of and support for CE for ongoing, 
new, and emerging vaccines in India. Participants included heads of communicable disease 
control, preventive medicine, maternal and child health, and played leadership roles in vaccine 
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policymaking, vaccine financing and/or planning and implementing national-level vaccination 
programs in the field of vaccine research, development, and roll-out. 
 
Study Participant Recruitment and Data Collection 
Study participants were recruited first from the professional network of the principal 
investigator (Dutta) and then expanded through snowball sampling. Recruitment emails 
explaining the study purpose were sent in December, 2017, and thereafter followed up with 
phone calls to identify interest and availability in an interview. All except two participants 
confirmed participation in the study after two follow up contacts during December, 2017.   
 
Profile of Study Participants 
All but two participants were currently employed with active decision-making roles in 
vaccine programming and policymaking. One participant who retired recently is currently 
engaged as a Chair of various vaccine research and development ethics committees for vaccine 
clinical trials and pilot projects. Another participant, after retiring from the Ministry, is now 
working as a Consultant to a NGO active in downstream CE and policy advocacy for uptake of 
vaccine and other biomedical prevention tools. Both these participants thus shared their 
perspectives on CE while being a part of the Government earlier and now as a part of non-
profits and other regulatory bodies. Most study participants had backgrounds in epidemiology, 
pediatrics, virology, or vaccinology, and three had specializations in humanities: medical 
anthropology, health management, and social work. Table 4 describes the profile and 




At the time the study was undertaken, there were no studies in India on CE in the 
vaccine policy formulation and program planning space. The interview instrument thus drew 
upon studies that had explored CE factors influencing the uptake of new vaccines and conduct 
of vaccine clinical trials in developing countries (Sundaram et al., 2015; Uddin, et al., 2013; 
Leon, et al. 2012). Semi-structured open-ended, face-to-face interviews lasting 45-90 minutes 
explored: (1) participant’s conceptualization of community and CE, (2) evolution of CE, (3) 
fostering support for CE, (4) resources available for CE, (5) partnerships for CE, (6) community-
level enablers of CE, and (7) community-level barriers to actualize CE. This format facilitated the 
free expression of opinions by participants, allowed for probing and clarification of responses, 
and enabled identification of new issues and topics as they arose. Interviews were conducted 
between December 2017 and February 2018, audio recorded, and thereafter transcribed 
verbatim by the lead researcher. Field-notes written within the 24 hours of each interview, 
reflected on the interviews from the perspective of the researcher with focus on how the study 
participants presented themselves including non-verbal communication. 
 
Data Coding and Analysis  
For confidentiality purposes, names and affiliations of all respondents were 
anonymized. Participants’ responses were referred by the organizations to which they belonged 
to, categorized into five types: (1) MoHFW and its research institutions, referred to as the 
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Ministry (2) immunization technical committees under the aegis of MoHFW, referred to as 
technical committees, (3) UN agencies, (4) donors, and (5) NGOs.  
 
Data coding and analysis was done using NVivo 12 (QSR International, Melbourne, 
Australia). Two coders joined the principal investigator (Dutta) to independently code a sample 
of the interviews (N=5 each). This was followed by a coding conference to negotiate consensus 
with 90% consistency for inter-coder reliability for final nodes through inductive and 
deductive methods. This helped emancipate the researcher’s position in appropriate meaning 
making of the data (Lofland and Lofland, 1995; Stake, 1995; Maxwell, 1996). The outcome was 
a coding structure with 7 multi-dimensional CE themes with 42 nodes. The remaining 20 
interviews were coded by the primary researcher using the negotiated final coding scheme.  
 
Results  
Study participants described their roles in leadership positions to foster and promote CE 
for vaccination gains. Five participants mentioned their roles in expanding CE strategies in 
vaccination programs in other Low and Middle Income Countries (LMICs) of Asia, Africa and 
Latin America, places characterized by high disease burden, low vaccine confidence, and huge 
unmet vaccination needs.  
 
Conceptualization of Community  
Overall, in envisioning CE as interventions “for the community, and in the community,” 
participants unanimously acknowledged that CE “ultimately boils down to trust” between the 
51 
decision-makers and the communities. Recollecting their own experiences, they mentioned 
that regular and early engagement with the communities facilitated better vaccination 
outcomes, even in the case of otherwise contested vaccines, like HPV, especially in the under-
served areas and among minority communities.   
“We have never faced any challenges with the introduction of HPV vaccines. We gave 
the first dose to the girls in 2016 and then the second doze and expanded the program in 
other districts in 2017. Again, whatever target we had set, we could reach almost 98% of 
it. We always go to the community and have media campaigns, have interpersonal 
communications. We use all sorts of communication channels to make people 
understand what we are going to introduce and give to their children.” 
 
In defining CE, participants conceptualized ‘communities’ in several different ways which 
can be broadly categorized as: (1) vaccine-eligible and priority populations, (2) vaccine 
gatekeepers at the local levels, (3) local-level stakeholders who impart information to 
individuals, or groups in order to encourage vaccination uptake among the vaccine eligible 
populations, and (4) local-level stakeholders, whose messaging at a community-level influences 
both individual vaccination decisions and herd immunity (Table 5).  
 
[Table 5]  
 
Most participants conceptualized communities as priority populations for vaccines such as 
eligible children, young persons, and pregnant women. Ensuring full immunization to them 
under GoI’s UIP was identified as the most important goal, and, as described later, the prime 
purpose for ‘doing’ CE. Three participants representing organizations who conducted vaccine 
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clinical trials explained communities as healthy, uninfected potential trial volunteers or vaccine 
trial participants, in addition to the communities where these people lived. 
 
“Communities included adolescents and adults and in some of the areas some particular 
sub-populations in relation to HIV and vaccine trials like the commercial sex workers or 
individuals working in the health related institutions. I think we were not just limiting 
communities to the subset of the population who participated in clinical trials, it was the 
whole communities in which those individuals were living.” 
 
Some participants identified community as vaccine gatekeepers, which included people 
like mother-in-laws, husbands, and religious leaders, especially in minority communities who 
either resisted vaccine introduction and delivery or influenced vaccination negative decisions 
among the priority populations.  
 
“….like in Mallapuram the mother generally said ‘no’ to vaccination and because their 
husband lives in the Middle East (whom they should ask and seek permission regarding 
the child’s vaccination). We (decision-makers) then realized that we have to find a way 
to tap the Indian men who are influencing immunization acceptance back home.” 
 
While most participants suggested or narrated targeted interventions with vaccine 
gatekeepers, one person expressed that they avoid working with ‘activists’, especially those 
associated with any anti-vaccine political groups.  
 
“…we do not work with outright activists. We are very happy to work with the critics of 
us and the Government, or of the system, but not with activists.” 
 
Most participants connoted the 3A’s as “community within their own community” 
because they were considered trusted by the communities they serve These 3As comprised of 
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the Auxiliary Nurse Midwifes (ANM), or the Multipurpose Workers (MPWs), responsible for 
administering vaccines among < 5000 people; Accredited Social Health Activists (ASHA), and 
Anganwadi Workers (AWW), literally translated as ‘courtyard shelter’ workers, who live and are 
responsible for promoting maternal and child health, including interpersonal communication 
for full immunization coverage among <1000 priority populations. 
 
Likewise, grassroots organizations working on maternal and child health, community 
based organizations (CBOs) like women’s self-help groups (SHGs), religious leaders of minority 
communities, and representatives of unorganized occupational groups like brick-kiln workers 
and barbers were considered communities by all interview participants due to their role “to 
help with community demand for routine immunization.” Vaccine trial-conducting organizations 
considered their CABs as communities, whose role was being a conduit between the research 
community and trial volunteers.  
 
There were a few instances where local-level representatives of technical and youth 
organizations were also referred to as communities. These included members from the local 
chapter of the Indian Association of Pediatricians (IAP), Indian Medical Association (IMA), 
Rotary Club, Lion’s Club, National Cadet Corps, National Service Scheme, and Nehru Yuva 
Kendras, who performed advocacy and outreach work to encourage families to immunize their 
children against polio and promoted other vaccinations in India’s highest-risk districts.  
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Despite expressions of heavy reliance on the 3As and local-stakeholders in meeting 
UIP’s immunization targets, their CE roles seemed different. The ANM and AWWs were salaried 
staff for vaccine administration among communities, the ASHAs received honorarium for 
counselling and escorting the communities for vaccinations, whereas the local NGOs and CBOs 
informally engaged and were instrumental in carrying out community-based activities to 
motivate community’s vaccination decisions and were conduits between researchers and 
vaccine clinical trial participants. Two participants, one at the Ministry and another with a GoI 
research institute, mentioned having Memorandum of Understanding with Rotary and Lions 
Clubs, and peers in local NGOs, while another with a donor organization highlighted non-
financial incentives to the community-level influencers. 
 
“For schools which had more than 90% coverage, we gave some felicitations 
(certificates) to the local headman. Certificates were distributed by the Medical Officer, 
which motivated the community. But there was no monetary incentive.” 
 
Some participants discussed NGOs and the media, though it was unclear whether these 
were considered as community or not. Again, several NGO heads, and those with an academic 
background in the Humanities, considering their community-inclusive approach, identified 
themselves as the community. In most of these expressions, it was not just the variety of 
conceptualizing community, but also a government versus community divide which was 
evident: 
 
 “The need for community ownership, they need to understand that they are not ‘they’, 
they are ‘we’. It is all a team, not researcher and community but “us together.” 
 
55 
“Somehow with the Government in every country, they want to clip our wings. This is 
very sad because we bring up issues that are affecting the common person, which, as a 
Government you might not even know or see.” 
 
In contrast, the media was referred to with a caution by participants. The concern 
expressed was mostly “to stop negative media”, “so that they (mostly meaning mass-
media) do not blindly publish.. so that media does not overplay and sensationalize when 
it is not an Adverse Event Following Immunization (AEFI).”  
 
Conceptualization of CE 
Participants’ CE conceptualizations was varied and expressed as segments of processes 
rather than any precise definition broadly classified as: (1) vaccine policy and program 
formulation for vaccine introduction among communities (2) capacity-building and stakeholder 
communication on vaccines and vaccination (3) vaccine information dissemination among 
communities and (4) targeted community-level interventions each, discussed separately below. 
One participant stated: “Every policy maker has a good intention for CE but there are very few 
recipes available for successful CE models.” Irrespective of CE conceptualization, its ultimate 
goal was driven to “….understand what is going on in people’s minds (regarding vaccines and 
vaccinations).” 
 
- Vaccine Policy and Program Formulation  
Many participants expressed CE as a top-down approach of vaccine policy formulation 
and vertical delivery of program guidelines intended for vaccine-eligible populations. 
Participants explained that vaccine leadership begins with the MoHFW, which then delegates 
vaccine policy design, operational guidelines, and training modules to its technical advisory 
bodies such as the NTAGI, Standing Technical Sub Committee, and Mission Steering Group. 
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These bodies develop the program from these directives and send it back to the Ministry for 
vetting before dissemination to the states. A vertical, top-down structure and management was 
expressed as follows: 
 
“If you think of a chandelier, the Ministry (MoHFW) is the hook. The different lights are 
the different partners, they are held at right distances in the right manner; meaning in 
immunization, the roles are well defined and there are very clear partnerships and no 
duty shedding.” 
 
While all the participants indicated that vaccine policy was guided by the National 
Vaccine Policy, 2011, they could not indicate any CE specific policy or guideline. Three 
respondents cited the Communication Strategy for Polio Eradication, a document by UNICEF 
and USAID (CORE Group), detailing strategic communication approaches to reach the last child 
with polio vaccination as the nearest to a CE guideline they would envisage. Similarly, vaccine 
introduction and rollout, participants described, was guided by a vaccine-specific operational 
guideline, developed in English and Hindi (the national language of India) at the national-level, 
which were thereafter disseminated to the states. Participants mentioned that specific 
revisions suiting socio-cultural needs or translation in the local language were mostly done at 
the state-level, though there were no examples of any material where any special item was 
added, removed, or edited to address the community-specific needs.  
 
 “…the guidelines goes from the Ministry to the state and then they modify it if they think 
that something is to be added or deleted.”   
 
Decisions to introduce new vaccines were made at the Ministry level after the vaccines 
were licensed. The MoHFW and its technical advisory groups would consider factors such as 
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disease burden, vaccine cost, cold-chain, and supply chain issues. Most participants at the 
Ministry, donor organizations, and UN organizations acknowledged financial support of the 
MoHFW and the international donors, and were optimistic about the recent strategic endeavor 
by the MoHFW through its Mission Indradhanush (MI) and Intensified Mission Indradhanush 
(IMI), targeting 90% coverage by the end of 2018.  
 
“… Immunization is a vertical program and the central ministry bears all the operational 
and logistics costs. States are supposed to implement that.” 
 
More than half of the participants, while noting vaccination policy and guideline 
dissemination as CE, criticized chasms in this one-way, top-down policy formulation and 
program delivery. They did identify limited spaces like the Village Nutrition and Sanitation Days 
(VHND) - organized once every month at the AWC the rural child care center - for priority 
populations and local stakeholders to express their viewpoints, if any. However, heads of five 
organizations and technical bodies expressed that this, “working in silos” was “not real CE”  
 
“The system creates silos which can be a disadvantage. Every policy maker has a good 
intention for community engagement but there are very few recipes available of 
successful models of community engagement.” 
 
- Capacity building and stakeholder communication for CE   
Another predominant conceptualization of CE was building the capacity of the vaccine 
implementers (the 3As) so that they engaged effectively with the community in motivating 
them to be fully immunized. This occurred through capacity-building trainings conducted by the 
GoI and UNICEF on the usage of IPC and SBCC materials and vaccine-specific operational 
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guidelines. Participants at the Ministry and UN organizations discussed the Training of Trainers 
(ToT) imparted by the national and state-level immunization officers using the Boosting Routine 
Immunization Demand Generation (BRIDGE course). Though considered comprehensive, most 
decision-makers thought that three days stipulated for the BRIDGE course was rather 
insufficient to train the frontline healthcare providers on all aspects of CE. Linked to this, the 
participants strongly felt that the 3As were the ones to ‘do’ CE, because direct CE from the GoI 
level is not feasible. Only one participant stated contrary to this, indicating that leadership’s 
presence was desired at the community-level.  
 
“Communities want the leadership to come to them and talk to them. …just sit with 
them, work with them and that is the key to CE. The leader does not need to go to the 
community every time. But at least once or twice if he or she goes, it really increases the 
confidence of the community.” 
 
In addition, there were several examples of training the local-level influencers, such as: CABs, 
peers, local religious leaders, and members of CBOs, to build community-level champions, who 
in turn, played multiple roles to: facilitate the vaccine providing organization’s entry to the 
communities, work as effective conduit between the researchers and communities, and 
eventually help vaccination uptake or effective conduct of vaccine clinical trials: 
 
“As a XXX researcher, if I went to the community nobody will accept me, but they will 
listen to the peers. So peers became the voices of our organization. They were also 




Again, participants were divided in their perspectives about whether the cascade training of the 
3As or TOTs of the local stakeholders was an expression of CE, but it did appear as if CE was 
delegated to them:  
 
“So, you piggy back everything that the Community Health Worker, who goes and talks 
about immunization, family planning, maternal health, school health, adolescent health, 
non-communicable diseases, and cancer… [but] you are not actually engaging or doing 
CE.” 
 
One participant mentioning the structural gaps, critiqued the flaw in defining CE in this way: 
“The Immunization technical Unit was not built with a community engagement model 
for immunization. Like you compensate ASHAs for children fully immunized and trainings 
attended not for CE.” 
 
- Dissemination of Vaccine Information  
Most respondents, despite realizing that information sharing and dissemination of 
interpersonal and socio-behavior change communication (IPC and SBCC) is an oversimplified 
and incomplete definition of CE, admittedly used ‘communication’ and ‘CE’ interchangeably, 
and mentioned that “CE is messages sent down” (for vaccination uptake). One participant 
repeatedly mentioned, “The role of CE, I mean communication, sorry using the wrong word 
again.”  In the same vein, the Communications Officer was denoted as the human resource for 
CE by almost all the participants. Community-based social mobilization and communication, 
participants said, came in waves, and was most noticeable during vaccine introductions, before 
and during vaccine trials, in case of a disease outbreaks. 
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One participant conceptualized this form of CE as bilateral information transfer, another 
understood it as a means for communication between the community and government. Some 
remained top-down, describing CE communication as question/answer sessions to increase 
vaccine uptake:  
“….we sat with communities and asked if they wanted to talk with us. So, we would ask, 
why the children were not getting immunized. Then they would ask what the harm is if 
they did not get immunized? Or what is the advantage of getting immunized? So you 
would sit down and answer their questions.” 
 
This same conceptualization also held the information to be going the other way: from the 
community to the government in service to the vaccine program goals: 
 “…so, the feedback came from the panchayat leaders, ASHAs, and the community. …like 
if you have identified a construction site, did the mapping and when you entered the 
data and reached the community after a fortnight, they have already moved. So the 
local person could tell us the whereabouts of the mobile community and we could reach 
them through the ASHA network.” 
 
Another participant from a state which had piloted the HPV vaccine, highlighted the critical 
importance of vaccine information dissemination in doing CE and meeting vaccination targets:  
“…we could reach almost 98% target. We always have media campaigns, go to the 
people and have interpersonal communications. We use all sorts of communication 
channels to make people understand what we are going to introduce and give to their 
children to protect them from certain diseases.”  
 
Another component which the participants mentioned was information dissemination 
through media trainings, “State Immunization Officers are trained on how to handle the media.” 
Similarly, sensitization of the media was mentioned mostly as a means to “stop negative media” 
especially regarding Adverse Events Following Immunizations (AEFI), so that the media does not 
over-sensationalize when it is not an AEFI.” This is linked to the earlier expression where media 
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representatives were treated as a part of the community by some participants, while others did 
not agree to this nomenclature.  
 
Increasing trends of engaging with celebrities and local officials as role-models to 
motivate communities’ vaccination decisions came across as another communication channel 
for CE by some participants, while quite a few expressed otherwise, and were unsure about the 
effectiveness of this strategy to involve communities or ensure vaccination uptake.   
“So, we used to keep the vials in front of the community and ask them to choose, 
whichever they wanted. We said we do not differentiate between a Hindu and a Muslim 
child. The Deputy Collector used to vaccinate his child in the (community), and then they 
(the vaccine eligible adults or those with vaccine eligible children) believed.” 
 
“I think our communication campaigns are pretty pathetic. I mean what is the point in 
having a XYZ (an iconic film star and a celebrity in his 70s, now) there? I mean that he is 
there on every advertisement. We have no way of measuring that. Does he convey safety 
of the product? To sell a toothpaste or a phone we spend hundreds of millions of dollars, 
just to really understand the consumers mind and to figure out what triggers things. 
How much is going into selling something far more important as vaccines?”  
 
Three participants, considering the diversity in India, said, “Every mile the language 
changes, the culture changes” and favored having a “village-level communication strategy.”  
Describing vaccine information dissemination using traditional mechanisms like print and 
mobile mediums, some participants highlighted the need to explore use of web-based social-
media platforms like Facebook, WhatsApp and Twitter, considering digital media’s easier usage, 
cost effectiveness, and penetration in interior areas of the country:  
“Earlier messages were through mobile texts. Who is there to read your texts? Nobody is 
interested. So, messaging is getting more and more creative. So, if my GIF is giving a 
message there is more likelihood that people will pass it on.” 
“…in the rural areas, maybe 50-60% would use Facebook. Versus 100% use of text 
messaging and WhatsApp.” 
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- Targeted Intervention and Community Emancipation 
Participants generally held a utilitarian conceptualization of CE as a mechanism to 
“increase vaccine demand generation.”   
 
“…(W)e are currently planning to work on demand issue which will involve the 
community through social mobilization.”   
 
While there were several expressions of CE as targeted program interventions, 
responses showcased a wide range, from top-down enforcement of vaccination on 
communities to respectful engagement with the communities, typically with vaccine 
gatekeepers and minority populations, especially in areas of high vaccine resistance and low 
vaccine confidence: 
“In XXXX district (name not disclosed) community was very resistant and they were not 
even allowing the vaccination team. Yes, physically resisting, they started beating us. 
Then we had to contact a local muscleman, briefed him, convinced him that this 
(carrying on with the vaccination drive) is important, and then told him to make an 
announcement that vaccination is not a bad thing.” 
 
“We engaged universities like Aligarh Muslim University, Jamia Milia Islamia and Jamia 
Hamdard, and their staff went out to the field to orient the local religious leaders so that 
they spoke with the communities. That also helped to address the issue of hesitancy.” 
 
Some participants highlighted best practices from the earlier NPSP period like the 
‘Underserved Strategy,’ which had its genesis after a polio outbreak in Uttar Pradesh in 2002 
among the Muslim populations and the ‘Social Mobilization Network’ formed in 2001 as a direct 
intervention to reach out to families to immunize their children against polio. As another 
example of CE, a participant mentioned ‘My Village my Home’ (MVMH). It is a pictographic 
vaccination tracking method in the shape of a hut, with vaccination details of each new born 
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child born in the village that year, filling each brick in each column of the hut. The project was 
under the Maternal and Child Health Integrated Program (MCHIP) funded by the USAID Bureau 
for Global Health under its flagship maternal, neonatal and child health (MNCH) program 
(Sample picture of MVMH in Appendix C). This would be posted in the health sub-center (SC), 
and allowed each parent to identify if they had missed any vaccines for their children. 
Participants perceived these peer-conversations and vaccine sensitization as CE leading to the 
community’s empowered vaccine decision making.  
 
In designing community-sensitive vaccination programs, and ensuring that efficacious 
vaccines become effective among communities, one respondent said, “it is a marathon, and not 
a sprint.” indicating CE as a time-and resource-intensive process. Another reiterated, “See, CE is 
an expensive process. It took me 20 years to learn about community and how to engage with 
community.”  
 
While several participants envisaged ideal CE as a community empowering process, one 
participant cited the example of HIV and conceptualized CE as a way to develop community’s 
agency.  
 “HIV has set an example for other diseases also of how communities can get engaged, 
how they can advocate for their own cause and then there could be an equal partnership 
between a practitioner, community and the programmers. So, HIV is a success story in 
our country. We are seeing HIV control through community engagement.” 
 
One participant conceptualized community agency and stated CE as:  
“Demand generation is another thing. It means that you (government/vaccine 
providers) are giving we (vaccine eligible community) are accepting, and policy 
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influencing is that where the community thinks that certain things needs to be changed 
or certain things which they have issues in accepting the way it is being delivered or 
designed. Like, if the community thinks that oral vaccines are easier than the others, are 
they influencing the government to change?” 
 
Fostering of CE 
All the participants acknowledged the value of CE for vaccination uptake and reducing 
vaccine hesitancies, though the description of how they championed and advanced CE during 
their decision-making roles covered a spectrum. In some cases, relationships among decision 
making organizations appeared to be fractious. Most of the participants recognized issues of 
incompatibility between scientists and communities, admitted that practicing the right CE is a 
complex decision, aspired to re-examine the starting point for CE, and recommended the need 
to expand the accountability of decision-makers to communities. They also felt that an overall 
sense of trust of communities for vaccines needs to be instilled, so that each time a new 
vaccine is introduced, incidents of community resistance and backlashes do not re-occur. For 
example, one participant said: 
“… but the moment you come back, it will be the same thing again. The moment you 
leave the village, others will come and say, ’Are you mad that you listened to these 
people and got your child vaccinated?”  
 
Responses from participants’ narration of their roles in owning, advancing, and integrating 
CE with immunization efforts could be categorized in a spectrum of seven different expressions. 
Though a strict categorization of responses by organizations would not be accurate, patterns of 
CE-fostering roles by participants’ organizations could be deciphered. 
 
65 
(1) The first was a single example from a research institution where the priority 
community’s emancipatory role was acknowledged by its Director.  
(2) The second kind of response showcased reliance on frontline healthcare workers for CE 
and vaccination delivery, mostly expressed by the technical and program heads.  
(3) The third were those responses where organizational structure and policies supported 
inclusion, and the senior management team was both knowledgeable about 
community-level issues and had intermittent direct connect with the communities. 
These responses were mostly from the vaccine research organizations.  
(4) In the fourth group, there were participants who often went out of their way and 
proactively did CE activities and innovative interventions because they thought that it 
would help the vaccination outcomes of a certain community. This group mostly had 
participants who were responsible for the introduction and roll out of vaccines, 
especially in under-served areas or where its uptake was low.  
(5) In the fifth category, there were leaders who thought CE should be done because it was 
mandated by the national government or by global leadership. These were mostly from 
the Ministry, GOI level.  
(6) The sixth kind gave examples where they propagated CE because it was central to 
performing one’s duty.  
(7) The last were those responses where vaccines were imposed on the communities using 
force, with responses from program heads, who had to meet certain vaccination targets. 
All the seven categories with one exemplar quote for each category are summarized in 




In expressing how they owned or fostered CE, each participant cited several examples of 
community-specific outreach and targeted interventions during their tenure. These incidents 
took place during vaccination campaigns, vaccine introductions, or as a part of routine 
introduction, wherein vaccination uptake among eligible populations had to be ensured. 
Therefore, these interventions often signaled innovative strategies to ensure vaccination in the 
program under reached areas, and among the minority communities where suspicious 
regarding vaccination as another political agenda to selectively use anti-fertility agents were the 
highest. Again, most of these examples reiterated a critical reliance on local stakeholders and 
health care providers as catalysts in converting vaccine hesitant behaviors to vaccine adoption 
behaviors. However, participants did not mention any institutionalization to sustain, replicate, 
or scale-up any of these unique strategies. Some examples were as follows:   
 
“Among the migratory brick kiln workers many children remained unimmunized. So we 
approached the brick kiln owners and got the list of all the children which we sent to the 
Government officials so that these children were vaccinated. Because there were 1000s 
of brick kilns and if you left them out then you do not vaccinate 1000s of children!” 
“It was also very difficult to catch hold of fathers, who used to go to work in the day. So 
we thought of another strategy, because the men will talk and not listen. So, we went to 
the barbers’ shops. That was the only place where the men used to shut up or else they 
would get cut. XXX (The Information, Education, and Communication Officer) gave some 






Evolution and transformation of CE 
While all the participants admitted that CE in the vaccine space has evolved since 2010, 
they mentioned that the communities’ memory of top-down impositions of prevention 
methods/tools by the system had impacted communities’ lack of vaccine confidence over these 
years. One person said: 
 
“..the vaccine fear was connected to the family planning program, when women were 
forcibly sterilized.”  
 
As an aftermath of this top-down imposition sterilization programs, erroneously poised as CE, 
participants noted that CE’s relational gains have been affected and that the trust between the 
community and systems have been damaged over the decades. Relevant quotes are as follows:  
 “The trust in the system, the trust in the research, in the manufacturing, regulatory, also 
the policymakers trust who administer the vaccines. And so a clear understanding of 
each other’s trust is important, because ultimately the immunization relies on trust.” 
 
 “….it is very difficult to build trust in the community...like we told the XXXX worker, 
‘don’t put the picture of a pregnant lady on the IEC material, because immediately the 
community will relate it is with pregnancy and have the notion that something will 
happen to the newborn child..” 
 
In summary, all participants indicated that understanding about CE was still evolving, 
and that it was a “very poorly understood space,” “complex,” and “several gaps to understand 
this puzzle.” Three participants critiqued that in practice CE is “offhand,” “ad-hoc practices to 
douse the fire,” “firefight,” or “control big chaos and help put things back to normal” and called 
for “real community engagement”, and a “scientific approach to CE.” One participant from a 
research institute mentioned: 
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“We were not really very serious and formed a small community group. (Initially, the 
community group) heard us, had some snacks and went off. CE really didn’t go beyond 
that. But by then at high level institutes (NIH and USAID funded projects) CABs had 
become really very active and CE became an important area (of development and 
intervention) for us.” 
 
Most participants acknowledged the push and handholding to understand and 
implement CE from global donor partner organizations, and some described direct involvement 
of the GOI in recent times, in acknowledging the importance of CE for ethical conduct of 
vaccine trials and effective uptake of vaccines. Specifically, the financial support and capacity 
building by the GOI, the U.S. Centers for Disease Control and Prevention (CDC), the WHO, GAVI 
- The Vaccine Alliance, and the U.S. National Institutes of Health (NIH), were mentioned. This 
evolution can be seen in the following exemplar quotes: 
 
 “IAVI has done in-person hand holding because they had a country office whereas NIH 
always looks for community engagement. So unless you have community engagement, I 
do not think that you will be considered also. Initially we had a CAB because NIH wanted 
it. But then we learnt how necessary it was.” 
 
“GAVI funding, which partly went to cold chain strengthening but partly also went to 
improving community mobilization.”  
 
In narrating the evolutionary process of, participants in the Ministry provided a few 
examples showcasing genesis of a two-way, direct interface between communities and policy-
makers.  
 
“..there is more CE now after the new Government has come. The Prime Minister’s Office 
invites suggestion from the public. Many things come to us through emails and we reply 
to them also.”  
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 “In the MI program our Health Minister goes directly to the ASHAs and ANMs of each 
village..we issue letters to each and every ASHAs and ANMs.”  
 
While being optimistic about the CE in the current times, several participants indicated a 
need for more regular, direct, and lateral rather than top-down discussions between decision-
makers and communities, and emphasized documenting the qualitative and relational gains of 
CE:  
 
“If we close the doors once again to the community, we might not get the communities 
back, ever again. We will lose trust and lose what we had promised.” 
 
“I think, as a country, I will not be ashamed to share, very poor in documenting. The 
learning that have come out of polio is so humungous ... but you will hardly see any 
papers. This is so because the people who are doing it do not have the time and the 
capacity to do that.” 
 
Discussion  
To the best of our knowledge, this is the first study outlining conceptualization and 
support for CE by national-level vaccine decision-makers in India. To date, there had been no 
‘elite’ interviewing in this field of study in India, possibly considering methodological, and 
reflexivity issues, and that vaccine introduction processes and community resistance were 
playing out in real time (Lancaster, 2017). Thus, an inherent challenge to this study was that it 
would have been difficult to find alternative interviewees if any study participants declined to 
take part in it. Another methodological challenge was gaining access to the study participants in 
the Ministry, and more so to building trust with them during a limited time, especially, those 
with whom the researcher was interacting with for the first time. However, the researcher’s 
familiarity with some of the study participants who were not in the Ministry, understanding of 
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the vaccine governance and gatekeepers at the national-levels, knowledge of opening question 
which would be of interest to the study participants, and an overall sensitivity about the 
strategic vaccination environment in the country helped to circumvent these anticipated 
relational and interaction barriers (Kezar, 2003).  
 
In carrying out this study among 25 purposefully selected vaccine decision-makers, 
being an Indian, knowing the field, and being from an American university gave me (the primary 
researcher, Dutta) an elevated status of an 'informed outsider' and allowed for considerable 
interpretive latitude and probing opportunities within discussions, and put the researcher in the 
context of an insider (Laurila, 1997; Hunter, 1995; Bowen, 2005). Some of the study 
respondents were initially reluctant to interact candidly. This was partly because of 
bureaucracy, but mostly because policymakers were busy in planning the introduction of 
multiple vaccines, and addressing media outrage and concerns regarding vaccine safety and 
efficacy, or were occupied with executive meetings preparing answers for vaccine-specific 
questions raised in the then ongoing Winter Session of the Parliament, which the 
Health/concerned Minister is obliged to answer. Notably, all of the community uproar in the 
NCR and several other states demanding stalling of the HPV and M-R vaccines has taken place 
during the same time (Cheatham, February 26, 2018 Duke Global Reproductive Health Indian 
Express, Saxena Dec 2017; Firstpost, Nair, Dec 2017). Due to these tumultuous circumstances, 
researcher’s readiness and flexibility to re-schedule appointments after office hours or on 
national holidays, spending additional time and money for follow up calls and visits to the 
participants’ offices, were important to carry out these interviews effectively. Literature on in-
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depth interviews with elites and government officials have highlighted flexibility and 
knowledgeability on the researcher’s end as key (Conti & O’Neal, 2007; Stephens, 2007; Berry, 
2002; Harvey, 2011; Thuesen, 2011; Zuckerman, 1972). Future researchers involving 'studying 
elites or studying up' should be conscious and sensitive about the topic and the country’s 
political environment to ensure objectivity and integrity of the data (Sabot, 1999; Welch et al., 
2002; Shenton & Hayter, 2004, pp. 223-231).  
 
The choice of India for this study was both appropriate and pertinent because the 
country’s Vaccine Policy (2011) recommends generating community acceptance for new 
vaccines as also maintaining confidence on the existing vaccines, especially where community’s 
vaccine resistance is reported. Moreover, in the current context, the country has been declared 
polio-free after years of an intensive polio vaccine campaign has introduced four new vaccines 
in its UIP during 2017, and through the GOI’s IMI, aims to accelerate vaccination coverage to at 
least 90% of children by 2020 (MoHFW, Govt. of India). While we had located several studies 
examining vaccine research and roll-out analyzing CE, most of them were project-or-program-
specific, describing community vaccine utilization, vaccine clinical trial participation, or 
examining vaccine confidence and trust. None was a country-specific study examining decision-
makers’ overall meaning making of CE, or summarizing what has been done till date to improve 
CE (Gopichandran, 2017; Ozawa and Stack, 2013, Mcqueen et al., 2015; Newman et al., 2011; 
Larson et al., 2016).  
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Interviews with organizational heads and immunization leads clearly elucidated that 
decision-makers, by virtue of their long experience in India and other LMICs, were 
knowledgeable and sensitive about the local, historical, and social contexts of marginalization 
and exploitation affecting the community’s relationship with public health systems and 
authorities. This study did not identify a consistent or a neatly-fitting definition of community, 
and found CE that is an evolving process rather than an endpoint. These narratives explained 
study participants’ own interactions with communities during their tenure, and highlighted how 
the CE interventions were reframed by social, bioethical, disease, and donor demands. 
However, these examples were context and individual-specific and thus cannot be generalized 
to other settings.   
 
Despite an egalitarian understanding of CE, most participants failed to make the leap 
from the top-down community mobilization, targeted at achieving immunization goals, to 
approaches working in consultation and partnership with communities. O’Mara’s systematic 
review of CE and health inequities also found a higher prevalence of utilitarian approaches than 
empowerment approaches (2013). Arnestein’s Ladder of Citizen Participation defines these as 
community-entry interventions and classifies them as ‘manipulation’, ‘therapy’, ‘informing’, 
‘consultation’, and ‘placation’ rather than empowered elements of CE showcasing ‘partnership’, 
‘delegated power’, or ‘citizen control’ (1969). Also, it was observed contextual nuances wherein 
participants displayed aversion of working with activists and anti-vaccine lobbyists, which is an 
exclusionary way to conceptualize communities. Such a perspective is not consistent with the 
‘whole community approach’, which is considered the most inclusive and dynamic 
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conceptualization of community (Morton and Lurie, 2013), and might risk having any CE 
strategies tailored for these sub-populations (Howard-Grabman, 2017; WHO, 2017). However 
this is very understandable, in the context to ensure vaccine introductions and uptake while 
needing to deal with hostile media, and community-level uproars. 
 
Leadership’s utilitarian orientation toward CE was also evident in their usage of 
incapacity-laden (rather than asset-based-words) like ruralites, urban slums-dwellers, vaccine-
hesitant, poor, illiterate, those from minority religions, and those residing in the vaccine under-
reached areas while defining the communities. While this utilitarian approach might be the 
most feasible to accomplish the vaccination mission in India, it defies the core of participatory 
work and could possibly inhibit progress toward having communities with vaccine-empowered 
decision-making capacities. Similarly, most participants’ silence regarding the internal chasms 
between the 3As due to their different professional roles, accountability mechanisms, 
remunerations, and power inequalities with the communities (Amin, 2005; Eversole, 2010; 
Mosse, 2005) risks reifying communities as internally homogenous entities. This is not accurate, 
especially given the class and caste-based diversities prevalent in India.  
 
We argue that a paradigm shift is needed from a reductionist approach of viewing 
communities (but not all the communities), especially those who avail vaccination services as 
the non-vaccinated, vaccine-hesitant, to seeing them as integral parts of the policy and delivery 
systems and recognizing their potential to play an active role in addressing vaccination uptake. 
Literature indicates that such a ‘beneficiary-oriented’ conceptualization of community and CE 
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can limit formation of trusted, sustainable collaborations with the communities, ultimately 
compromising generating critical qualitative information about communities, which only 
participatory research could render (Morgan, 2001; Taylor et al., 2005; Kilpatrick, 2009; Larson 
et al., 2015; Dutta et al., 2018; Tindana, 2007, Shonkoff, 2011).  
 
The top-down structure of vaccine policy making and programs, which often function as 
technical collaborations rather than soliciting communities’ active input on program or policy 
building, mirrors the ‘two-communities thesis’, which postulates that scientists and decision-
makers not only find it difficult to interact with non-scientific stakeholders, but even consider 
‘doing’ CE [from the national-level] as an ignoble business, thus reducing the potential to build 
community support, advocacy, and trust (Choi et al., 2018, Lin and Gibson, 2003 and Carlisle, 
2010). While Ramsbottom and colleagues (2018) suggest that national government-mooted 
public health initiatives might not be able to stray too far from a centralized approach, critical 
scholarship by Adhikari et al. has defined such top-down unidirectional CE as 'short-hand' 
(2016), often resulting in wasted resources, with the potential to create mistrust rather than 
enhance benefits, create legitimacy, or share responsibility (Ukpong 2008; Newman, 2006; 
Dickert & Sugarman, 2005).  
 
Incumbent to meeting the ambitious vaccination targets under the MI and IMI, CE often 
came across as an impromptu reaction rather than being embedded as an integral approach, 
mostly to fulfil donor mandates or deal with communities’ vaccine-related fears. Interestingly, 
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Carnegie et al. (2017) work states these approaches as barriers to CE planning, essentially to 
fulfil donor mandates. 
 
The deeper ambiguities regarding ‘real’ and ‘right’ CE, particularly in the face of 
recurring evidence of the communities’ shattered trust on vaccines and vaccine-provisioning 
systems, was concerning. Such a conceptualization render CE as a mere check-box or service-
add-on intervention, or just a signal of commitment such that, in the longer run, communities 
might become agents of the government, especially, when interventions are largely funded and 
offered at the discretion of the government and other donors (Dutta et al., 2018; Magtymova, 
2007; Head and Ryan 2003; Head 2007; Paterson & Larson, 2012; USAID, 2017). Here, CE could 
merely be a self and donor-ask fulfilling strategy, as Cooke and Kothari (2002) have argued, and 
though stakeholders were seemingly ‘engaged’, the modes of engagement are significantly 
nuanced and influenced by the existing donor-partner-government power dynamics. Similarly 
scholars have recommended examining the relationship between interventions and 
communities leading to changes in resources, capacities and cultures, rather than isolated 
impact evaluations of interventions (Hawe et al. 2009). 
 
Existing literature, has suggested signing memorandums with local partner organizations 
and beginning CE at the study design stages, which has not been the case with most programs 
in India (Lavery et al., 2010; Folayan et al., 2015). Further, studies show that although social 
media messaging is a cost effective mechanism for vaccine information dissemination by 
decision-makers, it might not be an effective mode of communication for everyone, and could 
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leave out populations who might be the most vulnerable to vaccine-preventable morbidities 
and mortality, many of those who are illiterate, lacking social media literacy, or are in locations 
with little or no internet, or are in situations where the language might not be tailored to the 
local dialects (Nepal et.al. 2012). 
 
Increasing interest in CE may require emphasizing its capacity to build transparent, 
meaningful, collaborative, and trustworthy relationships between community groups and 
decision-makers by strengthening each community’s agency for its own health, while 
addressing health inequalities, social exclusion, and the underlying social determinants of 
health (Carlisle 2001; Crawshaw et al., 2003, Department for Education and Skills, 2004; Leon et 
al., 2012). While in the current context several programs like the Grand Challenges Ethical, 
Social and Cultural Program, the NIH’s community-engaged research through its Clinical and 
Translational Science Award, and the SAGE working group exemplify increased foundation and 
federal funding and political commitment to support CE via research, networks, and 
communication interventions, concerted brainstorming for a more inclusive definition of CE and 
CE metrics for biomedical prevention tools like vaccines is highly recommended (Fagnan et al., 
2010; Lovan et al., 2017; Cavaye, 2004; Chalmers, 2004; Zerhouni, 2003). Specific mention of CE 
and CE outcomes in vaccine policy documents, with multidirectional and multiple points of 
exchange to understand and implement CE, is likely critical in realizing India’s immunization 
goals, while also building communities with empowered prevention choices. More narrative 
inquiries to further understand when and how engagement should start, best practices in 
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This paper has brought together the narratives of CE in the vaccine policy and praxis 
space by vaccine decision-makers in India. While there is growing impetus for CE by vaccine 
decision-makers, studies on the longer-term relational gains of CE, and its incorporation in 
policies will help more effective understanding and implementation of CE. Power imbalance 
created by the heavy reliance on Northern donors, and decision-makers’ traditional outlook 
about communities as ‘beneficiaries’, rather than ‘participants’ needs to be revisited. Future 
studies need to identify social and relational indicators of including social structures, which can 
track changes in vaccine sentiments among communities. Promoting CE without interrogating 
the terms of such arrangements can be counter-productive, creating new structures that might 
unintentionally reinforce potentially harmful social structures and mistrust between 




USING THE SOCIAL ECOLOGICAL MODEL TO ANALYZE COMMUNITY ENGAGEMENT FOR 
VACCINATION IN INDIA 
Abstract  
Introduction: There is high-level policy consensus that community engagement (CE) improves 
vaccination uptake and reduces burden of vaccine preventable diseases. However, to date, 
vaccination barrier studies in India have not focused on CE, nor identified enablers and barriers 
for CE affecting vaccination uptake in India.  
Materials and Methods: Key informant interviews were conducted in India among 25 national-
level vaccine decision-makers and triangulated with 24 national-level vaccine policy documents 
and researcher field notes from December 2017 to February 2018. A follow-up meeting was 
conducted with participants in December 2018 and January 2019 to verify observations. The 
Social Ecological Model (SEM) is used to organize and report study findings.  
Results: There were more CE barriers than enablers identified at all SEM levels. Policy-level 
enablers included political-will and policy documents promoting social mobilization, whereas 
barriers were lack of a CE strategy document and an ambiguous understanding of CE. At the 
organizational-level dissemination of Social-behavioral Change Communication (SBCC) materials 
from the national-level to the states was considered a CE facilitator, while power-relations in 
the community, lack of family-centric CE strategies, and paternalistic attitude of decision-
makers with communities and NGOs were considered CE barriers. At the Organizational-level, 
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partnerships with local organizations were considered CE enablers, while lack of 
institutionalized support to formalize and incentivize these partnerships were barriers.  
At the interpersonal-level, SBCC training for healthcare workers, sensitive messaging to 
communities with low vaccine confidence, and social media messaging were considered CE 
facilitators. The lack of plans to manage vaccine related rumors or replicate successful CE 
interventions during the polio campaigns for newer vaccines were seen as CE barriers.  
Conclusion: Future studies should attempt to associate these identified factors with particular 
CE outcomes such as participation or community support from vaccine policy making stages to 
its uptake, or sub-population based incidents of community resistance hindering vaccination 
uptake. Developing operational definition of CE, having step by step policy guideline for CE, 
communication materials considering intersectionalities within communities, and CE indicators 
in national datasets is recommended. Additional studies should document CE best-practices 
and study implementation and effectiveness CE interventions in the vaccine space.  
 







Countries increasingly are encouraging community engagement (CE) in planning and 
implementation of activities to improve vaccination uptake and completion (Oyo-Ita et al., 
2016). This is likely because CE has been effective in mobilizing communities for uptake of 
vaccination services, which reduces the burden of infectious diseases, increases herd immunity 
thresholds (Betsch et al., 2017), promotes health equity, and enables countries to achieve the 
Sustainable Development Goals (Tadesse et al., 2017; Pramanik, et al., 2018).  
 
India is one of the 194 member countries who endorsed the World Health Assembly’s 
Global Vaccine Action Plan framework envisioning that communities understand the value of 
vaccines and demand immunization as their right and collective responsibility, with a goal of 
reaching 90% immunization coverage at the national-level (Cherian and Okwo-Bele, 2014). 
However, the latest available data from by MoHFW show that India’s vaccination rate is 62% 
(NFHS 4, 2015-16). To increase the coverage, in 2014, the Government of India’s Ministry of 
Health and Family Welfare (MoHFW) launched Mission Indradhanush (MI), and in 2017 
launched the Intensified Mission Indradhanush (IMI), especially targeting communities who are 
mobile or isolated, and populations with low vaccine demand and/or high vaccine resistance 
(Gurnani et al., 2018). There are also persistent caste, class, and gender-based inequalities in 
vaccination outcomes in the country (Pramanik, et al., 2018; Pande and Yazbeck 2003). 
 
Most studies focusing on communities’ non-vaccination identify vaccination refusals and 
hesitancy as issues, attributing them to religious, social, and philosophical reasons (Pelčić et al., 
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2016, Shankar and Dutta, 2010), lack of trust of the vaccine providers (Muñoz et al., 2015), fear 
of vaccines, and adverse outcomes following immunizations (Goldstein et al., 2015). Weigmann 
(2017) identified mandatory vaccination as an infringement on freedom of choice in the 
community. Another study partly attributed lower vaccination rates to the top-down structure 
of India’s immunization program; the national-level defines overall policy and financial 
decisions, states determine implementation, including allocation of resources, and local areas 
conduct interventions (Pande, 2003). These findings are reflected in perceptions that 
interventions framed as CE are ‘scare tactics’ (Larson et al., 2011), or top down information 
provision campaigns without opportunity for community involvement in planning, monitoring, 
and surveillance activities (Donaldson & Preston, 1995; Sabarwal et al., 2015). Such 
interventions are often cited as examples of community mobilization (WHO, Ebola Training 
Community Engagement) rather than CE. Salathé and Bonhoeffer (2008) suggest that this lack 
of CE causes lack of trust in, and delegitimizes vaccination programing (O'Neill, 2002; Yaqub et 
al., 2014). Other scholars attribute vaccine hesitancies, refusals, and even backlash to 
questionable or nonexistent CE efforts (Mellerson et al., 2018; Jansen et al., 2003). 
 
Vaccine decision-makers or ‘elites’ (Aberbach and Rickman, 2002) by virtue of their 
knowledge and position of authority as well as vaccine policy documents, drive policies and 
programs from the national-level, and can jointly elucidate the complexity and effectiveness of 
CE implementation in order to improve vaccination coverage (Rhodes et al., 2016; Pope, Mays, 
& Popay, 2006). However, literature on intensive elite interviews, also referred to as ‘studying-
up models’ (Hoch child, 2009), highlight that they are infrequently conducted because these 
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people are hard to reach, surrounded by gatekeepers, and have the power and ability to 
protect themselves from intrusion and criticism (Hunter, 1993; Laurel, 1997). Thus, this study 
followed elite interviewing using personal resources and unique methodologies, with the aim to 
identify enablers and barriers to CE for vaccination services in India. Synthesizing information 
on elite CE conceptualization and implementation would bridge this evidentiary gap and 
enhance current literature which is mostly based on views of communities, or local 
stakeholders (Habib et al., 2017; Johri et al., 2015).  
 
Materials and Methods  
Data Sources and Inclusion Criteria 
The study employed a multi-method qualitative approaches to identify the key enablers 
and barriers to CE for vaccination uptake in India. The data sources consisted of (1) a set of 
semi-structured intensive elite interviews with vaccine decision-makers in India, supplemented 
by follow-up convening meetings with these participants to clarify particular points discussed 
during the interviews; and (2) national-level vaccine policy documents in India.  
 
For this study, ‘elites’ were defined as vaccine decision-makers who had been in positions of 
authority [of at least 7-10 years] and were responsible for: formulating vaccine policies and 
programs in India, signing off on the introduction and roll out of vaccines under the UIP, and 
carrying out vaccine clinical trials between 2010 and the present. ‘Vaccine policy documents’ 
refers to any national-level strategy, and/or guidelines in India with the purpose of sensitizing 
frontline stakeholders on the immunization goals, and the communities on vaccination gains; 
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jointly published since 2010 by the MoHFW and the National Health Mission (NHM)- India’s 
flagship health-sector program to revitalize rural and urban health (Harvey, 2011; Mikes, 2012). 
 
First, an exhaustive list of 30 vaccine decision-makers was prepared based on informal 
discussions and networking by the primary researcher (Dutta). This list was taken to represent 
the national-level vaccine decision-makers and immunization partners in India; 28 elites were 
selected from. Of the total 30, two could not be reached out to because one did not have a 
physical office in India, and another could not be contacted. Initial recruitment emails were 
sent to 28 individuals in December 2017 explaining the study purpose and seeking their consent 
to participate in a one-on-one in-person interview. Follow-up emails and phone-calls were 
completed in early January 2018.  
 
Second, Boolean internet search was conducted to identify pertinent vaccine policy 
documents from October to December 2017 using the following search string: ‘vaccine’ AND 
‘policy’ OR ’guideline’ AND ‘India.’ The result was 20 policy documents. Additional documents 
were identified by study participants. All documents were available on the websites of the 
MoHFW, NTAGI, country offices of the WHO, UNICEF, and CGPP. Inclusion and data collection 
process is explained in Figure 3 in the Methods section in the earlier chapter. 
 
This paper uses SEM as an organizing framework for data analysis because it describes 
factors at multiple levels, including intrapersonal, interpersonal, institutional, community, and 
policy. The selection of the SEM reflects the multi-level nature of vaccine interventions, and 
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likely attempts at or conceptualization of CE. For example, policy-level factors include policies 
and regulations affecting communities and institutions, community-level factors are often 
functions of the relationship among different institutions within communities, organizational-
level factors constitute institutional organization and management, interpersonal-level factors 
include interactions of individuals with families, peers, neighbors, and healthcare workers, and 
individual-level factors include vaccine-related beliefs, values, and other individual factors 
(Crosby, Salazar, & Decremented, 2013; Oku et al., 2017; Rainey, 2011). Although SEM is a 
widely accepted model, and used in several vaccine studies (Kumar, 2012; Nambe, Hal, and 
Kamden, 2016), and vaccination and vaccine clinical trials have studied communities’, program 
personnel’s and healthcare providers’ perceptions of enablers and inhibitors of CE (Kirk dale, 
2016; Wising, 2012), no study has used SEM to characterize and understand barriers and 
enablers to CE for vaccination in India.  
 
Data Collection 
Interviews were conducted from December 2017 to February 2018 in the country offices 
of the participants, in the National Capital Region, which is in or around New Delhi, the capital 
city of India. Interviews were audio-taped and field notes were taken in parallel. Since the 
outcome variables of interest were barriers and enablers to CE, the questions in the interview 
guide addressed the following broad areas: participant conceptualization of CE, the evolution of 
CE specifically during vaccine introductions, and positive and negative factors which affected 
fostering CE during their tenure. In the earlier chapter, I have defined the conceptualization of 
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CE (Dutta et al., in review). Interviews lasted 45-60 minutes and were conducted in English. No 
financial incentive was provided to study participants.  
 
Content analysis of the vaccine policy documents was completed separately, but in 
parallel with interviews and field notes of these interviews. The documentary evidence, 
combined with data from interviews and observation, allowed the researcher to counter 
threats to trustworthiness, such as reactivity, minimized respondent bias, and established 
credibility, while identifying CE themes and CE-related enablers and barriers.  
 
A final step involved convening a follow-up meeting with participants as a group in 
December 2018 to present and verify study observations. Some participants invited their work 
teams to participate during the discussion and three participants, invited the researcher to 
meet them separately in January 2019. There were no appreciable changes to the findings 
based on the feedback.  
 
Coding and Data Analysis  
A deductive, thematic approach informed by the SEM framework initially was used to 
identify recurring and emerging themes. This was followed by a clustering of data into nodes 
and sub-nodes (Hsieh et al., 2005; Elo and Kyngäs, 2008). A priori coding included SEM levels 
and barriers/facilitators of CE. CE enablers and barriers for vaccination were then classified into 
all the SEM levels. 
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Thereafter, line, sentence, and paragraph segments of transcribed interviews, policy 
documents, and field notes were reviewed repeatedly to identify barriers to and facilitators of 
CE. Two additional and independent researchers coded a sample of 5 interviews and 2 policy 
documents to assure study rigor. A coding conference was held to identify and negotiate coding 
discrepancies. Categories with coding differences were addressed and re-defined through 
iterations until a consensus of 90% was achieved (Smith et al., 2000). The preliminary codes 
helped the coders integrate concepts already well known from the extant literature (Andersen, 
1995). Care was taken not to compulsively fit data into predefined codes, though a ‘start list’ 
(Miles and Huberman, 1994) allowed new inquiries to benefit from and build on previous 
insights.  
 
The concepts identified were reintegrated into themes, which now provide the structure 
for the study results. This led to a form of pattern recognition, with emerging themes/nodes 
becoming the categories for analysis (Fereday and Muir-Cochrane, 2006), and contained 
barriers and enablers for CE with 10 key underlying factors. All the 25 interviews and 24 
documents were re-coded by the lead researcher using this finalized instrument. Nvivo 12 (QSR 
International, Melbourne, Australia) software was used to organize the data.  
 
Results 
Twenty-five vaccine decision-makers participated in the interview. Of them, two held 
Secretary-level positions, the highest office at the MoHFW for the UIP. Seven participants from 
technical and research institutes under the aegis of the MoHFW were responsible for vaccine 
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policy, operational guidelines and program formulation and approval, vaccine supply and cold-
chain management, and certifying ethical conduct of vaccine clinical trials. Participants (n=3) 
from three UN organizations oversaw vaccine surveillance, uptake through social mobilization, 
and training of local stakeholders. Immunization heads in donor organizations (n=3) led 
strategic partnerships along with the MoHFW and ensured vaccination funding. Four technical 
heads from three multi-country, multi-partner projects, and six country-leads of non-
governmental organizations (NGOs) collaborated with the government, donors, and technical 
partners in ensuring achieving the UIP goals or conducting the clinical trials (Refer to Table 4 in 
the earlier chapter).   
 
Twenty-four vaccine policy documents were identified and reviewed for this study. Two 
documents on social mobilization and communication, and one on partnership, were published 
by UNICEF and CGPP - a multi-country, multi-partner initiative to strengthen in-country efforts 
in sustaining the polio eradicated status of India, and GAVI, the Vaccine Alliance - a public-
private global health partnership to increase access to immunization in GAVI-eligible countries. 
More than half of the documents (n=15, 62.5%) were published during 2015 to 2018 and were 
vaccine-specific operational guidelines introduced during those years by the Ministry. 
Depending on their content, the documents could be classified into five categories: Policy and 
program review documents (n=3, 12.5%), vaccine and program-specific operational guidelines 
(n=7, 29.1%), Frequently Asked Questions (FAQ) booklets for communities and community-level 
stakeholders (n=3, 12.5%), Adverse Event Following Immunization (AEFI) documents (n=3, 
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12.5%), and Social and Behavioral Change Communication (SBCC) and social mobilization 
related documents (n=8, 33.3%). An overview of the documents reviewed is given in Table 7.  
 
[Table 7]  
 
Narratives of the elites and content analysis of the vaccine policy documents identified more CE 
barriers than facilitators at all the SEM levels. The outcomes are summarized and shown in 




Policy-level CE Facilitators 
At the policy level, there were 2 CE facilitators and 5 CE barriers. Enablers included the 
increasing political will to enact CE and elite intent for bottom-up (community-driven) CE 
measures. This was expressed as a desire to interact with and engage communities during the 
introduction and successive roll-outs of four new vaccines under the UIP between 2016-2018, 
and piloting of contested vaccines like Human Papilloma Virus (HPV) vaccine in three states. 
Some spoke about this as current behavior while others reflected on the evolutionary bi-level 
teaching and learning processes that took place:   
 
“..introduction of any vaccine in the State has never been a challenge. We always go to 
the community and have media campaigns, we go to the people and have interpersonal 
communications. We use all sorts of communication channels to make people 
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understand what we are going to introduce and give to their children to protect them 
from certain diseases.” 
 
“First the schools were not so involved, but then Karnataka showed us the way (that) the 
schools are involved and we improved our strategy so that in the next phase the school, 
teachers and students are involved in a big way. This was an example where we did mid-
term corrective evaluation. That is why I am saying that involvement of the community is 
very important.” 
 
More than half of the participants cited that direct contact between the decision-
makers and communities facilitated CE. This contact could take place in a variety of ways such 
as direct engagement in person or even by email:  
 
“Because our email IDs are there on the website, emails (stating that) ‘my child has not 
been approached for full immunization,’ or ‘this vaccine is not available in my 
community’ come to us, or directly to the Minister or the Prime Minister’s Office; and 
then we reply.” 
 
Participants recollected regular home-visits by the national-level decision-makers during 
the National Polio Surveillance Program (NPSP) as a CE enabler. NPSP was a campaign of the 
WHO and MoHFW initiated in 1995 to ensure polio eradication through house-to-house 
poliovirus vaccine delivery: 
 
“When you go to a village, there would be lots of people who would hang around for 
curiosity sake. So, then we sat with them and asked if they wanted to talk with us. We 
would ask, why the children were not getting immunized. Then they would ask what the 
harm is if they did not get immunized? Or what is the advantage of getting immunized? 





Policy-level CE Barriers 
Most participants acknowledged decision-makers’ complacency with a ‘social 
mobilization’ approach to vaccination uptake, implying that this was preferable to the work of 
‘doing real CE.’ These participants identified a dearth of ‘institutionalization of CE,’ which they 
thought had reinforced the distance between the decision-makers and communities.  
 
 “They (implying Government) only focus on vaccines. If they work on vaccines I am very 
happy. Which means that we have high level political will.  We have the Prime Minister 
tracking vaccines and everything on community engagement should be happening now. 
But it is not happening, that is for sure.” 
 
Notably, most participants critiqued the abovementioned community and home visits as 
‘ad-hoc CE’, clustered during NPSP, which was designed to be delivered through home visits, or 
undertaken during vaccine introductions, especially in pockets of disease outbreaks to mitigate 
communities’ vaccine-and vaccination-related anxiety. One person labelled this as ‘dousing the 
fire’ rather than ensuring sustainable CE and another quoted below denied any direct and 
empowered communication between the communities and the decision-makers. 
 
“Communities need to be given a platform where they can share their viewpoints. But it 
is not there. If this were there, these leaders and policymakers would need to think twice. 
There is no direct channel of communication between the community and the policy 
maker. These public responses is thought of when there is an adverse event, like in Tamil 
Nadu recently for M-R vaccine campaign.” 
 
Two participants commented on the lack of any CE indicator in national-level datasets, 
or any studies examining the CE effectiveness as barriers to strategically defining, planning, 
implementing, and assessing CE.  
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“The demand side barriers are very special in and of themselves and they require 
engagement and they require understanding. It cannot be done with one coverage 
evaluation survey done six years ago which says 40% of this (lack of immunization) is 
because of demand. I cannot unpack that. I can do nothing with that information.”  
 
More than half of the participants reported the lack of any dedicated policy guideline 
document on CE. This included the absence of village-level communication plans. However, a 
few policy documents, such as Communications for Development by UNICEF, Strategy for Hard 
to Reach Populations, and CORE Communication Strategy, were cited by participants as being 
the nearest to any CE strategy. Notably, there was no evidence of any community involvement 
in formulation of these documents. Further, while decision-makers mentioned translation of 
these documents to the national language (Hindi) and other scheduled languages spoken in 
different States of the country, there was no evidence of these documents being available in 
any local dialects or mother-tongues. 
 
Community-level CE Facilitators 
Publication and decentralized dissemination of targeted SBCC materials from the 
national-level to the states, districts and local levels was identified as the only CE enabler at the 
community-level. Specifically, these activities facilitated community-level interactions among 
those with high vaccination resistance and low vaccine coverage for improved vaccination 
decisions. Participants described a variety of interpersonal and media messages, 
reminders/prompt messaging through mobile phones and WhatsApp, door-to-door canvassing, 
and strategic ‘miking’ (the use of itinerant megaphones) informing the dates for specific 
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vaccines and urging communities to complete the vaccination schedules. These were mainly 
completed by frontline health care providers and local role models who include religious, 
political, and trade leaders among the rural communities, and migrant laborers like brick-kiln 
workers, those belonging to minority religious groups like Muslims, and Scheduled Castes and 
Scheduled Tribes -the last two being constitutionally designated as historically disadvantaged 
people. 
 
“See, the communication materials are developed in English and in Hindi by us and then 
it goes from the Ministry to the state and then they modify it. If they think that 
something is to be added or deleted or modified.”  
 
Several policy documents reiterated the need to address vaccine-related structural and 
cultural barriers in order to mobilize vaccine hesitant and resistant communities. This was 
evident from titles like ‘FAQ on Immunization for Religious Leaders, Media Persons, CSOs, 
Influencers & Other Stakeholders’ and sections in the ‘Social Mobilization’ document like 
‘Devote time to the selection, training, and support of community-based outreach workers’; 
‘Advance the participation of women as social mobilizers, vaccinators, surveillance officers, and 
leaders in polio eradication efforts’; and ‘Involve children in campaigns to help counter 
‘campaign fatigue’. A quote from the Social Mobilization document can explains tailored CE 
interventions:  
 
 “In group meetings called Ijtemas, held separately for men and women, both male and 
female leaders use exhortations from the Koran and the Haddiths to stress the obligation 
of parents to protect the health of their children.” (Source: Social Mobilization: Lessons 
from the Polio Project in Angola, Ethiopia, and India, September 2012).  
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Review of vaccine policy documents revealed use of group-based dialogues, dyadic 
approaches to vaccine-related information sharing, and engagement of community champions 
for information and communication dissemination.  
 
Community-level CE Barriers 
Most participants mentioned various power-relations linked to class, caste, religion, and 
gender relations within communities, which, though not related to vaccinations, impeded 
community health provider interactions and affected communities’ vaccination decisions. Three 
decision-makers narrated such incidents, which are paraphrased as follows:  
- An incident where the vaccination camp was organized closer to the higher caste 
person’s house leading to lesser turnout of the lower caste communities to this 
vaccination camp; second was a case of adulterated yellow potable water from a 
Government installed hand-pump when adjoining communities became suspicious to 
any Government initiatives, including vaccinations; and the third was of a weaver in 
Uttar Pradesh State who witnessed the loss of traditional livelihoods among the 
community after the advent of cheaper Chinese yarn, which instilled the fear that 
anything ‘foreign’ aka vaccines would systematically jeopardize their lives or livelihoods.  
 
Another participant reported: 
“I see an obsession with immunization, which may not necessarily mean community 
engagement, unfortunately. It may mean loud noise. It may mean perverse incentives. 
We will not give you cheap ration because you did not get your immunization. It may 
mean many things but the point is that what is the goal? The goal is to increase the 
immunization coverage. Community engagement might not be the prime to the 
administration....and maybe it is not so bad, but it is not the best way to engage with 
your community.” 
 
Some participants indicated that these inequities were expressed in other ways, 
suggesting that community members’ choice or decision to vaccinate was subjugated to the act 
of doing so.  
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“From the community point of view, I think both the Government and other stakeholders 
are talking down to them. I think that needs to change. In that arena, I do not think that 
we have progressed much in the last 10 years. We are still not telling the community 
what these (vaccines) are about. We are only telling them that they need to get them.” 
 
Another kind of power-related barrier was the frustration expressed by heads of NGOs 
who felt that the ‘Government is trying to clip their (NGO’s) wings.’ These participants 
recommended an ‘integrated approach’, though it was unclear how it would impact CE 
interventions or bolster linkages between communities and health facilities.   
 
While interviews revealed community level and community-decision makers power-
equations, these were not articulated in the policy documents. Documents were mostly 
preachy with little or no recommendation of ‘how’ to use the community action cycle, CE 
quality improvement approaches, or cultivating an enabling environment for optimal CE 
practices so that vaccination services are effectively utilized. For example: 
 
  “Enabling processes for rapid decision-making to allow building alliances and 
partnerships, both national and global, and for support to agencies for diffusion of the 
technologies into the social systems, should be in place.” (Source: National Vaccine 
Policy, Ministry of Health and Family Welfare, 2011). 
 
“This will help facilitate more comprehensive interventions in participatory planning for 
program activities, closer interactions with the communities, convergence and 
rationalization for undertaking broader child health initiatives.” (Source: UNICEF, 
Evaluation of Social Mobilization Network (SMNet) - January 2014). 
 
Furthermore, the language, especially in the AEFI documents, appeared to have a 
disempowered conceptualization of communities as beneficiaries, which has the potential to 
exclude disadvantaged groups from vaccine policy and vaccination initiatives too. For example: 
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“….engage and convince communities after India achieving ‘polio-free status’ especially 
mothers/caregivers on the importance of vaccinating their children again and again for 
and during polio campaigns.” (Source: Intensification of Routine Immunization: 
Communicational Operational and Technical Guideline, MoHFW, 2012) 
  
“…Visiting the immunization site, vaccine storage point, residence and locality of the 
patient and the treatment centers.” (Source: Intensified Mission Indradhanush, 
Operational Guidelines, 2018). 
 
Notably, there was an abrupt silence or change of topic when questions on contested 
vaccines like HPV were asked, which could also be a potential CE barrier. When participants 
were asked about the introduction of HPV vaccines, their responses were mixed. Five 
participants mentioned successful introduction of HPV vaccines in states and credited it to the 
intensive training of frontline healthcare workers. However, several others exhibited discomfort 
when plans for HPV vaccine introduction were solicited. One person changed the topic, and two 
other participants mentioned that they were not holding the office or that they did not work on 
HPV vaccines after demonstration projects were stalled in 2010. Further, there were no 
operational guidelines for HPV vaccines explaining its phase-wise introduction, which, in itself, 
could be a CE barrier, considering that HPV vaccines cater to a unique population (adolescents) 
compared to the general childhood immunizations provided under UIP. 
 
“……like you saw in HPV vaccines. (For) all vaccines the same public voice for policy 
change is not there, unless there is a problem or AEFI etc. And then also, policymaker 
thinks how to stop the immediate emergency, but not to empower the communities.”   
 
Organizational-level CE Facilitators 
Participants and policy documents highlighted partnerships with multilateral 
organizations such as GAVI, WHO and UNICEF, and inter-sectoral technical groups like ‘Mission 
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Steering Groups’ to promote and leverage CE. Such partnerships and Task Forces at the 
national, and state-levels promoted and advanced participatory approaches of bilateral and 
global partners.  
 
“Mission Steering Groups are people from various Ministries who determine the 
feasibility of implementing the recommendation, which includes elaborate and 
transparent processes.” 
 
“…when we talk of community engagement there are two platforms, one is State Task 
Force on Immunization and another is the District Task Force on Immunization, who have 
regular meetings.”  
 
Participants, especially from the Ministry, also acknowledged local youth organizations, 
namely National Cadet Corps (NCC), Nehru Yuva Kendra Sangathan (NYKS), National Service 
Scheme (NSS), and Rotary International, who partner and collaborate with the government to 
achieve the vaccination target of reaching every child. Most of these were volunteer-based, 
except for the Rotary Club, whose ‘SOP on Engagement of Youth Organizations and Rotary for 
Immunization’ was identified.  
Participants expressed their reliance on these local organizations, and credited them for 
undertaking social mobilization activities along with the ASHAs and AWWs in their respective 
areas to ensure full immunization of all children. They were also acknowledged as being 
involved in the district task force meetings, organizing advocacy awareness and infotainment 
programs alongwith public practitioners and local political, religious, and trade leaders, and 
regularly disseminating information through local media both using electronic and print 
mediums for vaccine-related awareness to support routine immunization and vaccination 
campaigns. The below quotes elucidate this: 
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 “Very recently Government of India has signed a MOU with Rotary. Actually, Rotary was 
previously involved. Rotary will help us with community demand etc. in Routine 
Immunization.” 
 
“The CBOs and CSOs: They are helping us to take our messages down to the community. 
Some of them are involved in community education, both in rural areas and urban slums, 
so that they are forthcoming to get the vaccines.” 
 
While the virtue of partnerships with local-level NGOs, and CBOs was equivocally 
acknowledged in the National Vaccine Policy, it was perceived as a strategy for vaccine 
development and outreach, rather than for CE: 
“ ..several examples where product development have taken the PPP route and have 
resulted in shortening of the time frame for vaccine development, such as the 
Meningococcal Meningitis Vaccine Initiative (MMVI), where the product was produced in 
India with multiple partners, met international standards in quality, was exported to and 
used in Africa. The model has been instrumental in indigenously 116E Rotavirus vaccine 
being developed with effective collaboration between Indian & US academia, and Indian 
vaccine industry in partnership with PATH.” (Source: National Vaccine Policy, Ministry of 
Health and Family Welfare, 2011). 
 
Organizational-level CE Barriers 
Participants highlighted the fact that efforts to collaborate with local groups like youth 
organizations, women’s SHGs, CBOs, and faith-based networks generally functioned without 
any monetary incentive or salary. Some participants mentioned refreshments/mementos 
offered to the NCC, NYKS, and NSS members during the sessions by the District Magistrate as 
incentives in order to acknowledge their efforts toward ‘good’ vaccination uptake. Here the 
assumption was that effective vaccination uptake was equivalent to successful social 
mobilization. Even so, this approach was rarely considered enough to motivate or appreciate 
the ‘volunteers’ appropriately by many participants, and was viewed as a barrier to sustaining 
these partnerships. 
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“These felicitations (providing certificates during a village gathering) were given to the 
local headman for more than 90% vaccination coverage, acknowledging their 
contribution. But there was no monetary incentive.” 
 
“No, we do not have any formal MoU kind of a thing with these CSOs and CBOs. They 
come and they have been working with us.” 
 
Neither responses nor documents identified any CE gold standards or cited any specific 
partnership strategy which showed improved satisfaction or positive relationships between the 
system and the communities.  
 
Interpersonal-level CE Facilitators 
Participants described about a noteworthy evolution in vaccination messaging tone and 
indicated that this was a CE enabler. There was a change from ‘vaccinate your child’, ‘Don’t 
forget vaccination your baby must get,’ to a message of ‘Be wise, fully immunize your child,’ 
published in the National Health Portal and all the community-facing SBCC materials like 
banners, leaflets, and advertisements in the mass-media. This includes the current tagline ‘5 
saal 7 baar, Choote na teeka ek bhi baar’ (depicting the importance of routine immunization 
with the message that a child should be immunized seven times in first five years of its life), 
which is endorsed by celebrities in every immunization advertorial. According to participants, 
the earlier frame of vaccination as a parental onus reflected the top-down nature of vaccination 
delivery, rather than engaging with communities, while the current messaging reflected the 
government’s realization that it must clarify the difference between vaccination and 
immunization, especially at a time when communities might be overwhelmed with several new 
vaccines being introduced under UIP.  
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Another participant explained the significance of the 'Mission Indradhanush' logo 
depicting seven colors of the rainbow: providing vaccination to seven vaccine preventable 
diseases diphtheria, whooping cough, tetanus, polio, tuberculosis, measles, and Hepatitis B.  
 
“Have you seen the logo of Mission Indradhanush, the rainbow, an umbrella of seven 
colors? It means seven colors of the rainbow and aims to immune the children from 
seven vaccine-preventable diseases.” 
 
This messaging change was related to participant recognition of the value of awareness 
generation about immunization and IMI using social media like Facebook and WhatsApp as a CE 
facilitator, especially in rural areas. They mentioned that social media platforms generated 
attention about vaccines among the rural, peri-urban, and hard-to-reach communities. 
“Like today there is a social media strategy after M-R (Measles-Rubella) campaign. 
Today Health Ministry is using its Twitter account and putting in people to tweet. What 
has Twitter to do with Health Ministry? But yes, it is becoming important. How do you 
send messages through WhatsApp so that the messages reach? Earlier messages were 
through texts. Who is there to read your texts? Who is there to forward your texts? 
Nobody is interested. So, messaging is getting more and more creative.” 
 
Considering the predominantly patriarchal society in India, IPC by healthcare workers 
targeting mothers-in-law and husbands was considered a CE enabler, correcting myths and 
misconceptions about vaccination and counseling them to ‘allow’ mothers to vaccinate their 
vaccine-eligible children.  
 
“…mostly the men talk and they will not listen. So, we went to the barber’s shops. That 
was the only place where the men used to be shut. (Our Communication personnel) gave 
some danglers (wall hangings) to the barbers. Barbers have associations whom we 
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approached. There are two kinds of barbers, who have fixed sites in shops/salons or they 
go to your house and cut your hair. So (Our Communication personnel) designed their 
aprons with messages for immunization. And then we taught them to talk to their 
customers around immunization of the latter’s child.” 
 
Inter-personal level CE Barriers 
Participants indicated that Training of Trainers (ToT) for the ASHAs, ANMs and 
Anganwadi Workers, such as the Boosting Routine Immunization Demand Generation (BRIDGE), 
sponsored by UNICEF, was a facilitator of CE because they taught inter personal communication 
skills (IPC). That said, they also indicated that such trainings needed more time investment to 
yield quality results, posing this as a potential barrier.  
 
“If you really look into BRIDGE training, you are building somebody's interpersonal 
communication capacities. Private companies invest huge amount(s) where they train 
their marketing personnel how to go and talk to somebody. Whether I am going to talk 
to the business executive or whether I am going to sell from door to door, that 
engagement strategy is a very critical and we need to invest more time and energy for 
that (in the BRIDGE trainings)”. 
 
One participant noted that missing out on SBCC materials for certain sub-populations, or 
not having any family-centric SBCC approach was a major barrier to CE:  
“Wives of men based in the Middle-East often did not get a timely affirmative 
vaccination decision, mostly leaving their children unvaccinated. We need to develop 
some strategy for this group” 
Review of the policy documents yielded several barriers to effective IPC and SBCC with 
the communities. Contrary to the expressed enthusiasm of participants about the use of social 
media for vaccine messaging, none of the policy documents highlighted the increasing 
proliferation of social media in rural and semi-urban areas. Most participants drew a 
relationship between communities’ negative vaccine experiences, either due to side effects or 
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vaccine-related rumor and misinformation. They also acknowledged that the relation between 
vaccination experience, vaccine knowledge, and rumors is complex, and the government lacks 
any rumor management strategies, especially when they are spread through the social media.  
 
“So that kind of engagement was very new to the Government and to the partners 
because there is already a negative atmosphere created at variety of levels, even before 
the introduction of the vaccine and that has a direct impact on the community.” 
 
The immunization FAQ booklets, though designed specifically for separate stakeholders, were 
notably similar. For example, the content was same for the following two FAQ documents: 
 FAQ on Immunization for Religious Leaders, Media Persons, CSOs, Influencers & Other 
Stakeholders, 2017 
 FAQ on Immunization for Parents & Caregivers, 2017 
 
In addition, while the ‘FAQ on Immunization for Health Workers and other Front-line 
Functionaries’ booklet mentioned herd immunity, it was not mentioned in documents for the 
communities. The AEFI-related documents emphasizing ‘managing communication in the case 
of an AEFI’ or ‘handling a rumor regarding an AEFI,’ contained several technical concepts 
needing demystification like: ‘immunization error related reactions,’ ‘immunization anxiety 
related reactions,’ ‘verbal autopsy form.’  
 
Individual-level CE Facilitators 
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There were several examples of participants recommending institutionalized support for 
more participatory CE, but no examples of anyone actually engaging with communities at an 
individual level. Two examples of individual interfaces were: home visits for polio vaccination 
(cited by participants) and investigation of serious cases post-vaccinations (mentioned in the 
Midterm Review Multi-Year Strategic Plan 2013-17, and AEFI documents). But since, by design, 
the polio eradication campaign (NPSP) was a house-to-house delivery program, and AEFI cases 
mandated an individual-level inquiry, these are not appropriately categorized as individual-level 
CE enablers. Only one participant cited ‘doing an extra bit’ in an individual capacity, which could 
be considered closest to an individual-level facilitator. However, it was for vaccination uptake 
rather than any CE outcome: 
“…delivering the vaccine last mile is one of the major challenges. There were two places 
where the vaccine was transported through helicopter. First time Government of India 
gave that fund. Although the beneficiary children were only 15 but we argued with the 
Government. I personally argued from UNICEF that if you say that 100% children are to 
be immunized somehow you have to send the vaccines to that place.” 
 
Individual-level CE Barriers 
The policy-level examples of decision-makers visiting the community or directly 
engaging with the community via email also figure at the individual-level. That said, participants 
mostly discussed the use of individual-level actions driven by policy decisions and experienced 
at the individual or community-level. An example was of the hiring of a ‘muscle-man’ to 
‘convince the communities to vaccinate their children.’ Interestingly, participants positioned this 
type of individual-level ‘coaxing’ as the only way to counter the demand-side barriers to CE 
such as: communities’ vaccine resistance, ignorance, lack of literacy, misinformation by target 
population (adolescent, adult), religious perception (Muslims fearing that vaccines will sterilize 
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their children, or something which is considered against their religious order), doses (confused 
between one-dose, multiple-doses, and not clear about the concept of ‘full immunization’), 
logistics (remembering to get the vaccine), and relationships with the local health provider. One 
participant said: 
“I would like to talk about the people who are not coming forward. This 10% population 
are the ones who are resisting. That is the population that needs to be taken care of, 
reached, or taken out of their home to reach the immunization sessions.” 
 
Summary of the Participants’ Follow-up Convening Meeting  
The participants’ convening meeting (full-day) was held in New Delhi on December 19, 
2018. Three participants who could not make it to this meeting met the researcher separately 
in their offices in January 2019. These meetings provided the opportunity for a review of 
observations and verification of results. Participants overwhelmingly agreed with the reported 
results and also worked together to develop an operational definition of CE while also had 
recommendations to improve CE in the vaccine arena.  
 
A comprehensive, and aspirational CE definition was formulated consultatively, and its 
importance was reiterated by participants and their working teams, most of whom managed 
Departments like Communication, and Vaccines Delivery:   
 
“CE is an upstream policy imperative, rather than downstream interventions to build 
trustworthy relationships between vaccine decision-makers and communities. It involves 
demystifying science and transparent communication for empowered community 
agency. This would enable communities to critically analyze vaccine related myths and 
misinformation and enable knowledge co-production in building community-sensitive 
vaccine policies and programs. (CE) is incumbent to sustained political-will and resources 
to ensure evidence-informed, tailored, vaccine policies and programs, providing 
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This study was the first to identify CE barriers and facilitators related to vaccination in 
India using the SEM framework. Triangulation of data through a staged process captured CE’s 
governmentalization during the Decade of Vaccines in India. Similar methodological approach 
by earlier researchers using organizational documents and interview transcripts yielded 
enduring results like: identification of overarching themes on performance in the nursing 
practice, technology-enriched curriculum, and a grounded theory of corporate turnaround, 
respectively (Fereday and Muir-Cochrane, 2006; Angers and Machtmes, 2005; and Pandit, 
1996). It also helped to understand the varied experiences of decision-makers in implementing 
CE for vaccination, while investments, intensification, and institutionalization were being 
recommended for, to realize the mission of MI and IMI (Malterud, 2001; Braun and Clarke, 
2006; Lewis and Ritchie 2003). This study directed attention to nuances like lack of any CE-
specific strategic document for vaccines, absence of dedicated staff to establish scientific 
mechanisms of CE in policies and programs, and a culture of silence for CE strategies for 
contested vaccines like HPV in India.  
 
Vaccine decision-makers’ expressed appreciation for the usefulness and timeliness of 
the study, both retrospectively and prospectively, to understand past CE challenges and 
successes and to appropriately plan for future vaccine introductions and roll out. The findings 
therefore contribute to two major discourses: the community empowerment discourse and the 
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systems discourse of CE. That said, due to various ongoing incidents of political activism and 
conflicts of interest between the vaccine provisioning authorities and the communities, 
decision-makers were cautious, to the extent that it was challenging for me to seek entry to the 
Health Ministry on certain days for data collection purposes. This was because of multiple 
reasons. At one end, the MoHFW had shelved the introduction of the HPV vaccine after 
representatives of a political party urged the Prime Minister not to introduce the vaccine 
because it ‘brings ignominy to the scientific community in the country and sells the country to 
vested interests’ (Outlook Web Bureau, January 10, 2018), while, at the same time rations 
(under the Public Distribution System of a Government scheme) were being denied to families 
until they vaccinated their children (Dabas, The Times of India, January 2018). Fortunately the 
researcher’s, prior knowledge of the sector and familiarity with the decision-makers facilitated 
circumventing these challenges with data collection (Hoch child, 2009).  
 
In other studies, vaccine decision-makers from Rwanda and Bangladesh have identified 
upstream drivers for effective vaccine introduction and rollout including research findings on 
vaccine-preventable diseases, participation of technical committees and professional bodies, 
political issues relating to disease outbreaks, and pressure from international development 
partners (Gatera et al., 2015; Uddin et al.; 2013). These studies have characterized CE within 
the commonly cited range: tailored vaccination strategies to the local context, engaging 
community health workers and local stakeholders for decentralized vaccine outreach, and 
community meetings to deliver information, about vaccination. However, such approaches 
reduce the community’s identity as ‘vaccine recipients’ with little or no agency to make 
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empowered vaccination decisions or invigorate their social capital for pharmacovigilance 
(Lindström, 2008). That said, this study also identified an overarching utilitarian 
conceptualization of CE by decision-makers (Dutta et al., under review), which, at times, 
seemed conflicting with their stated desire. For empowered and discerning communities 
demanding vaccines, and with policy documents without sufficiently detailed procedures to 
achieving such an aim. Here, we argue that this might not reflect a lack of effort by the vaccine 
decision-makers to address CE priorities. Rather, it could be function of the complexities 
involved in standardizing CE strategies for a diverse country like India, which has an annual birth 
cohort of 27 million [vaccine eligible children].  
 
While there did not appear to be an overt imposition of specific CE requirements by 
donors, its pre-determination to a considerable extent in accordance with government-
determined guidelines reflected some kind of a pressure on the implementing NGOs and CBOs. 
In this process, the latter could be mere implementers to the CE mandates, rather than 
becoming amplifying voices (Kawachi, 1999). 
 
Collaborative partnerships, are not a new means of improving community outreach for 
vaccination in India. However, challenges related to power differentials, timeliness, and 
accountability, innate to these partnerships need to be documented both in rhetoric and 
practice (Popay and Williams, 1998). For example, Lo et al.,’s work [partially] associates late 
engagement of HIV stakeholders in PrEP research to its implementation challenges. They claim 
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that early and deliberate engagement facilitates CE design and conduct of vaccine trials, and 
decreases likelihood of therapeutic misconceptions (2015). 
 
CE barriers identified in this study mirrored results from other evidence suggesting that 
top-down interventions, and engagement behaviors reinforcing power differentials, often are 
exacerbated by the community’s poverty and livelihoods crises, negative beliefs about 
vaccinations, and poor treatment of communities by healthcare workers and authorities (Favin 
et al., 2012; Larson et al., 2015, McQueen et al., 2015). Therefore, poorer, rural, minority 
communities, and women, were presented as the most conservative toward, suspicious of, and 
resentful to vaccines and vaccine provisioning authorities. Studies by WHO SAGE explain this as 
‘covert resistance by communities’ (Hilber et al., 2016; Shankar and Dutta, 2010), Betsch and 
Böhm identify this resistance as ‘reactance’ among communities to regain their constricted 
freedom of choice (2015), and other scholars have explained this as community members’ 
suspicions about the ‘sudden interventions’ by the authorities (Chaturvedi et al., 2008; 
Mavimbe et al., 2006; Oluwadare, 2009; Schwarz et al., 2009). Here, we contend that the Hard 
to Reach Population Strategy is area-based initiative building Health Action Zones (Powell and 
Moon, 2001), focusing on the poverty of places, and might miss on the relatively deprived 
families who might live outside these areas. While most decision-makers and policy documents 
in this study dismissed communities’ vaccine resistance as ‘not vaccine related,’ vaccine 
communication needs to address the social construct of vaccines. Specifically in the caste, class, 
and patriarchal context of India, community’s disapproval of government policies or 
paternalistic healthcare providers could be mostly dictated by upper class and caste-group 
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people or men, while it is the poor, minorities, and women who are often blamed by the 
authorities as being negligent to their children’s health. Further, intersectionalities and 
predicaments among the socio-economically disadvantaged are important to consider, as these 
communities try to negotiate between social pressures and preventive health, especially 
because subsistence typically takes priority over health in general, and immunization in 
particular, among these populations (Chaturvedi et al., 2008, Merten et al., 2011).  
 
Strategic CE needs to be done with vaccine gatekeepers. Studies suggest that this might 
enable access to potential vaccine users via those who interact with communities in their local 
dialects, while also empowering communities to make informed vaccine decisions by having 
debates between vaccine supporters and gatekeepers (Brian, 2016; Dutta and Lin, APHA, 2017).  
 
Though there was an overarching recognition that successful CE required 
demystification of vaccine-related knowledge among the community, examples in practice 
consisted of information sharing on vaccines, their side effects, and vaccine schedules (Earl, 
2001; Seeber et al., 2015; Noah, 2002). Kilpatrick (2009) fears that such biomedical training 
models can impede participatory approaches because trainees might be attracted to utilitarian 
gains rather than empowerment approaches to CE. This triggers to question the communities’ 
capacity-building on the science of vaccines. This is because most reported cases follow a 
minimum disease symptom post vaccination, which should rather increase the community’s 
trust on vaccine efficacy, because of the understanding that the occurrence of the disease can 
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only provide life-long immunity, and that is how precisely any vaccine works (Bisht and 
Coutinho, 2000). 
 
Furthermore, the element of herd immunity needs demystification (Stapleton, 2015) to 
enable communities understand the concept and assuage parental fear especially for babies 
who are too young to be vaccinated or immuno-compromised children, who are the first 
potential victims of low vaccination rates (Rapaport, 2018). Plotting of vaccination opposition in 
a timeline against vaccine introduction could help identify sub-population-based vaccination 
resistance patterns and design interventions accordingly.   
 
Research from developing countries has reported mixed findings on the choice of the 
form of IPC and SBCC for vaccine sensitization, ranging from community radio, and pictographic 
training materials, to prevention messaging through the television (Jackson et al., 2017). 
Growing economies like India need to make community-level investments reiterating vaccine 
benefits rather than building on threat perceptions. This can be done by (i) sensitive tailoring of 
innovative messaging using folk infotainment methods like sharing success stories of complete 
eradication of smallpox, and the near eradication of polio globally, and its eradication in India; 
(ii) simplifying technical differences, such as vaccination (which could be getting an injection or 
nasal spray or oral vaccine) and immunization, meaning receiving all the dosages of the vaccine 
and becoming immune to a disease, and (iii) translation of vaccine messaging to mother 
tongues and dialects because almost 200 of them, which are variations of the official Indian 
languages, are the predominant languages used by the indigenous and rural populations. With 
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the proliferation social media messaging, the usefulness of vaccine-related information needs 
to be weighed against rumors and misinformation spread (Alter and Redlener, The Hill, 
February 2019).  
 
Conclusions  
This study analyzed the methodological challenges and informational benefits 
associated with interviewing elites while conducting qualitative research, especially when the 
policy processes being studied play out in real time. A limitation of this study was that the 
factors affecting CE in a specific setting might not be interpreted correctly based on information 
from national-level decision-makers and policy documents. To address this, Dutta regularly 
summarized and fed back my interpretation to the participants during the interview to seek 
respondent validation.  
 
The findings from this study strongly indicate the need for evidence-based approaches 
to promote CE, such that the pursuit of health equity, which is central to vaccine introduction 
and roll out, is realized. Future CE barrier studies should identify key outcome indicators of CE 
based on a critical awareness of the history and nature of relations between communities, 
vaccines, and vaccine-providing authorities in diverse cultural, economic and political contexts. 
Immunization program evaluations need to include CE needs-assessments, map sub-population 
based expressions of vaccine hesitancies, and conduct formative evaluations of CE outcomes at 




CONCLUSIONS AND NEXT STEPS 
 
 In this study, the ‘whole community’ approach was applied to understand 
conceptualization, barriers and enablers of CE by national-level decision-makers and policy 
documents, in the case of immunization in India. This was done not only because it is the most 
inclusive definition of community encapsulating the full spectrum of individual community 
members as well as community-based organizations, but also because it is dynamic concept 
that changes with shifting environmental, socio-economic and political factors. Subjectivity was 
somehow inevitable given the diffuse nature of the concept, and the lack of more 
straightforward indicators of community engagement (Gallivan et al. 2012).  
 
 The uniqueness of this study and the differences in its outcome compared to other 
recent work (Pramanik. et al., 2018; Gopichandran, 2017; Nagar et al., 2016) which could be 
entirely due to the differences in the study objectives mostly looking at community-level 
demand-side factors which impacts vaccination utilization, timeframe, study sample, and the 
measures used.  
 
 Limitations of Study Design and Analysis  
A limitation in this study was the reliance on self-reporting by elites. Memory varies, and there 
is deterioration of the reliability of memory over time (Tourangeau, 2000). However, this study 
reports CE over the Decade of Vaccines and there was no other better way to obtain the data 
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than collecting it from national-level vaccine decision-makers. Also, triangulation of the findings 
of the narratives with review of policy documents and member check-in meetings, was another 
way to address this limitation. 
 
 One could question the social desirability concerns in the study, wherein study 
participants might have responded in explaining their roles because ‘doing CE’ is socially 
desirable. Social desirability was addressed by keeping the name and affiliation of the 
participant confidential and not ranking any of the CE practices as ‘best practice’ over another. 
Also, the researcher’s knowledgeability of the context of CE and vaccines in the country 
minimized skewing of the results. 
 
 A limitation was the lack of any measure of fidelity toward replicability and 
maintenance of standards in CE implementation. Again, there was no measure of frequency of 
use of a particular CE strategy. Though regarded as important by evidence-based practice 
researchers like O’Hare (2005), fidelity was not addressed in this study, thus conclusions 
concerning fidelity to practice CE standards are unavailable. 
 
 Generalizability beyond the sample itself was limited to the national-level vaccine 
decision-makers, and the vaccine policy documents. Because of this, the results of the study can 
be generalized to limited national settings where vaccine provisioning and governance, and CE 
implementation are similar to India. 
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Strengths of the Study  
 The main strength of the study lies in the conducting elite interviews of those who 
have been in the vaccine decision-making role for a decade or more. This allowed enriching the 
research with a variety of CE conceptualizations and understanding its evolution. The political-
will of vaccine decision-makers’ was obvious, and can serve as a marker of influence to allow 
research, education and practice of CE within the vaccination context in India. 
 
 The study invigorated the researcher’s confidence in ‘discovering’ newer routes to 
establish linkage and relationship with the elites: for example, beginning a conversation with a 
simple personalized greeting, rather than hurrying through the study instrument was helpful. 
Acknowledging another senior colleague who might have helped in connecting to the study 
participant was also useful. With extremely busy schedules, almost all participants received 
phone calls, or had brief interactions during the interviews. Attentive listening and reminding 
the participant of where s/he had left, not only facilitated continuing the conversation, but also 
helped in reconfirming what s/he was mentioning. Tailored use of social media like Facebook 
Messenger, or WhatsApp, for select participants who were comfortable with it helped in 
connecting more effectively and alluded some of the limitations of hierarchical, and centralized 
messaging. In the same breath, researcher’s humility was utmost important to probe at the 
right places in the right way while also understand issues/areas where the participants were 
not too comfortable in answering.  
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 Literature has noted that studies without using a particular theoretical lens has often 
led to conflicting and confusing results (Eccles, et al., 2005; Walker, et al., 2003). In this study, 
the adaptation of the hybrid of SEM and KFT to analyze conceptualization and implementation 
of CE through the Decade of vaccines in India, instead of personal cases stories (Rogers, 2003). 
The hybrid model allowed considering that there are variables at all levels from policy to 
individual-levels, which affect CE implementation. Also, the candid narratives of decision-
makers, and support to convene a follow-up meeting, reinstated the hypothesis about 
leadership’s positive intention to implement CE best practices for improved vaccination in India.   
 
Implications of the Findings 
Implications for Policy and Practice  
 The study results suggested intent and motivation of vaccine decision-makers to 
implement CE in the vaccine arena, who also came up with an operational definition of CE. This 
is an important predictor to exploiting opportunities for increased CE in the vaccine space.  
 
 The study findings highlighted that while vaccine policies and decision-makers in India 
have focused on vaccination uptake, planning, implementation, and improvement processes of 
CE have not been adequately reported. Decision-makers need for CE as a policy priority, 
including more practices of directly engaging with communities needs to be followed up and 
realized.   
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 Similarly, there were convincing examples during recent times to train the front-line 
providers enhance their quality engagement with the communities by utilizing m-health and e-
health technologies. In parallel, increased expressions of CE’s practice effectiveness needs to be 
captured in vaccine policy documents. Gubernatorial notes need to reflect confidence, that is, 
the ability of the vaccine decision-makers to push for a CE strategy and implement it. 
Apportioned resources dedicated for CE monitoring system would facilitate in carrying out 
studies to understand CE’s effectiveness rather than just tracking their implementation such 
that recurring instances of community backlashes and resistance might be prevented.   
   
Recommendations for Further Research 
 Study participants narrated CE implementation as linear implementation models 
occurring in stages, especially during vaccine introduction and roll out. An analysis including 
time as a moderating factor of vaccine decision-makers’ motivation to implement CE by social 
contextual variables might help mapping the CE evolution better. Toward that end, a 
longitudinal study design or a type of statistical analysis, which allows the use of time as a 
factor, such as using a structural equation modeling would be useful. 
 
 Another way could be to look at CE’s equilibrating influence (controlling community 
outrage, currently by using restraints on certain facilities to communities or by counselling and 
encouraging their positive vaccination decisions). Future studies need to explore which CE 
interventions works best in gaining community confidence and in enhancing vaccination 
coverage over what period. 
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 In addition, exploring CE in the nuances of intersectionalities, or the use of other 
theoretical frameworks, like Diffusion of Innovation can explain the relationship between CE 
interventions, exchange of information, and the adoption/utilization of vaccines as a product of 




 Consonant with theoretical understandings and evidence, the process of CE 
implementation in India manifested evolution and a better acceptance among decision-makers 
though in the overall understanding and governance of CE several shortcomings were noted. 
This study underscores that: (i) improving conceptual understanding of CE by policymakers, (ii) 
having well laid out CE strategies and monitoring mechanisms, (iii) investing in frontline 
caregivers to involve with communities in a respectful way, (iv) creating spaces and structures 
for empowered interactions between the decision-makers and communities will improve CE 
interventions in making efficacious vaccines effective for populations who need them the most.  
 
 Strengthening community health worker systems, mobilizing communities to address 
structural and cultural barriers, addressing vaccine-provider behavior and improving the quality 
of community-health provider interactions, will bolster linkages between governments, local, 
private stakeholders and communities. While this might not be any re-invention, it certainly 
needs research activism to acknowledge CE as a policy imperative to mature and develop 
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Table 1: Areas of community engagement and institutional mandate and support for the same Areas of 
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Table 2: Measures of community engagement factors for vaccination classified into SEM levels 
 
SEM Levels CE facilitating factors in the vaccine space 
Policy-level 
factors 
 Evidence of strategic engagement with communities during vaccination 
intervention and campaign planning and implementation written in policy 
documents. 
 Examples of political-will for CE especially among populations who needed it the 




 Evidence of class, caste, gender, rural versus urban related power-structures 
affecting CE between communities and authorities. 
 Examples of negotiations between the community and the vaccine providing 




 Evidence of formal or informal partnerships between national and local 
stakeholders (religious leaders, clubs, women's groups) who influence positive 
vaccination decision among communities. 
Interpersonal-
level factors 
 Evidence of transaction of Social Behavior Change Communication (SBCC) and 
communication between healthcare workers and local stakeholders and the 
communities to address vaccine related myths, rumors, and mis-information. 
Individual-level 
factors 
 Examples of direct communication between decision-makers and communities 
addressing vaccine concerns which impacting community’s decision to vaccinate 




Table 3: Exhaustive list of nodes describing conceptualization and support for community engagement for 
introduction and uptake of new and emerging vaccines in India, 2018. 
 
Conceptualization of Community Engagement 
1a. Egalitarian Perceiving communities as equal partners and leaders by vaccine 
policymakers. 
1b. Evaluative definition of CE  Opinion based comment on virtue of community engagement leading to 
vaccination uptake.  
1c. Ideal normative definition 
examples of CE 
Ideal definition of what community engagement should be, irrespective of 
what the organization is doing or not doing. Defining ideal community 
engagement processes which will lead to community engagement (goal).  
1d. Organizational interventions 
with or for CE 
The actual programmatic interventions with/at community-levels by the 
organization for vaccination uptake. 
(i) Community empowering        
interventions 
Processes leading to empowered communities. 
(ii) Personal narratives What the respondent did in her/his current or earlier position to engage the 
communities. Mostly use of first person 
(iii) Token interventions Roger Hart's Ladder of Participation which defines this as the lowest level of 
community engagement.  
(iv)  Top-down interventions Vertical program delivery and perception of community as beneficiaries, 
rather than equal stakeholders to vaccination program. 
 Communication and 
capacity building 
interventions 
Inter Personal Communication (IPC), Information Education and 
Communication (IEC), Behavior Change Communication (BCC), mass-media 
messaging for sensitization and awareness and capacity building trainings of 
workers, peer educators, health care workers and local stakeholders. 
 Supply chain management Ensuring supply of vaccines from the center to the ground levels. 
(v) Transactional interventions Dialogue with the community to build faith, trust and credibility for 
policymaker's/vaccine delivering system. 
(vi) Vaccination delivery by 
frontline HCWs 
Vaccination delivery by frontline healthcare workers (HCW) to vaccine eligible 
population. 
 
Evolution of definition of Community Engagement 
2a. Comparing Comparing different vaccine delivery/CE strategies across time or different 
vaccines, or comparing vaccination with other programs, urban and rural 
differences in delivery strategies and how things were/are done in other 
countries. 
2b. Evidence base scientific 
approach 
Learning from one vaccine experience, presence or lack of 
evidence/data/indicators of CE in the vaccine arena.   
2c. Institutional strategic 
orientation 
Organizational learnings and strategic orientations and shifts over time, across 
different vaccines and on the issue of community engagement in the vaccine 
space. 
2d. Opinion based Ideal opinions, more of rhetoric questions if that would work. 
2e. Personal narrative How his/her own conceptualization/role to engage with communities has 
changed over the years, in this and earlier organizations. 
2f. Transformative Macro transformations based on the burden of disease, vaccine availability 




Support to promote Community Engagement 
3a. Global stakeholders Support/help/solidarity of global partners and donors. 
3b. Ideal or evidence of other 
regions or institutions 
Support/help/solidarity of global partners and donors, or international 
collaborations of technical think tanks. 
3c. National stakeholders Support/help/partnership/solidarity of national-level organizations and 
national-level vaccine ambassadors or advocates. Political will of the 
Ministry/Prime Minister/Chief Minister.  
3d. Respondent's own 
organization 
Acknowledging enabling environment in the organization and support of the 
organizational head. 
3e. Self  
(i) Duty Performing his/her duty.  
(ii) Responsibility Self-motivated and performs beyond stipulated duty for innovative CE 
strategies. 
Resources for Community Engagement in the Organization  
4a. Financial resources Monetary resources within the organization which they have, or lack of 
finances. 
4b. Human Resources Human resources within the organization, e.g. Community outreach capacity 
of the organization - which they have or lack and should ideally possess. 
 
Partnerships for Community Engagement 
5a. With global entities Partnership with global organizations/and donors. 
5b. With national   
organizations/technical 
bodies  
Partnership with local organizations/technical body of the ministry/higher 
education institutions.  
5c. With local CBOs, CSOs, 
Youth Clubs, communities 
etc. 
Partnership with local CBOs, CSOs, Youth Clubs, communities etc. 
5d. Partnerships at 
organizational-level 
Ideal partnerships which would be helpful. 
5e. Organizational  Existing partnerships of the organization/institution.  
 
Community-level Enablers for Community Engagement  
6a. Local level influencers Religious leaders, clubs, women's groups who influence positive vaccination 
decision among communities. 
6b. Disease outbreaks Certain outbreaks which compelled parents vaccinating their children. 
 
Community-level Barriers for Community Engagement  
7a. Demand side barriers  
(i) Access Child sick or travelling or nobody at home to take the child to the vaccination 
site. 
(ii) Blackmailing and 
strategizing 
Communities strategizing with Govt due to lack of trust – like ‘build the road 
then we will take the vaccines’ or ‘what must be the plot of the Govt. to 
vaccinate’ etc.  
(iii) Fear and reluctance  Fear of illness or of death of child, fear of religious incompetence due to 
vaccination, arising from experience with this child, another child, neighbor’s 
child or media reports. 
(iv) Lack of information No knowledge about vaccines, no knowledge of vaccine schedules and lack of 
information about importance of the vaccines 
168 
(v)  Myths and Rumors Spreading of misinformation  
(vi) Power-structures in the       
society 
Structural barriers related to class, caste, and gender, rural versus urban 
hindering reach of marginalized communities to getting vaccinated. 
7b. Supply side barriers  
(i)  Access Health care worker not present in the session site, vaccines not there, 
vaccines there but have crossed the due date, vaccines could not reach the 
under-reached/under-served areas. 
(ii) Power-structures in the 
society 
Structural barriers like power relations between researcher and community in 
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Table 5: Epistemological categorization of communities by vaccine decision-makers in India, 2018 
 
Categorization of communities Constituting populations 
Priority populations  Parents of vaccine eligible children and young persons  
 Vaccine eligible populations who demanded vaccines  
 Key populations participating or potential participants to vaccine 
clinical trials  
Gatekeepers   Vaccine resistant populations 
 Husbands and mother-in-laws minority communities 
 Anti-vaccine lobbyists 
 Activists 
Local stakeholders  Frontline healthcare workers,  
 Members of local CBOs, clubs, SHGs 
 Members of local technical bodies  
 Bodies of local governance 
Unclear whether 






Table 6: Broad categorization of ownership and fostering of CE by vaccine decision-makers in India, 2018 
 
 Categorization of 
ownership and 




1. CE as a community 
empowering role 
“Some journalist misinterpreted and had adverse reports. Honestly, 
we didn’t get that much support from authorities in my headquarters 
but my CAB met within few days and went ahead and said that we are 
willing to give out rejoinder to this news report because we know you 
have been very very meticulous about protecting the individuals, have 
been transparent and sensitive to community.” 
2. CE as vaccine delivery 
with the help of 
frontline workers 
“I always appreciate my workers. The hard work that our ANMs and 
field staff are putting in in is tremendous. So if we have coverage of 
90%, it is not my contribution, it is all because of my field workers who 
are doing a great job” 
3. CE as a part of the 
organizational 
structure  
“There was the country and the regional programs where there was 
advocacy efforts to engage the community. There was a 
representative in the senior management team from the CRP. 
Representatives of the Board of Directors, who in one capacity or the 
other were the advocates of the community.” 
4. CE as a proactive social 
and altruistic 
responsibility  
“I remember there were two places in Tripura where the vaccines was 
transported through helicopter. First time Government of India gave 
that fund. Although the beneficiary children were only 15 I argued 
that if 100% children are to be immunized you have to somehow send 
the vaccines to this remote place. Else, it will take 7-8 days to reach 
there.” 
5. CE to comply to GOI 
and/or global 
mandates  
 “Since we did not have any great experience in vaccine trial and 
community engagement it (CE) was introduced to us through our 
sponsors and collaborators like National Institute of Health” 
6. CE as a duty delegated 
to the States and lower 
offices 
“No no, we do not do that part. Government of India does not run the 
programs at the peripheral levels.” 
7. CE as vaccine 
imposition/delivery  
“When children were dying and JE vaccine was introduced, people 
were fighting to get the vaccine. There was a firing in three places. 
People got a notion that if the vaccine stocks were finished we will go 
and their child will not get vaccinated, and so the rush and the panic 
‘me first’ ‘me first.” 
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Table 7: Overview of vaccines policy documents in India reviewed in this study, 2018 
 
Document type (N=24) Title  Publication year Publishing authority 
Policy and Program 
review documents (3) 
 National Vaccine Policy 2011 MoHFW, GoI 
 Midterm Review Multi-Year 
Strategic Plan 2013-17 
 Universal Immunization 
Program Reaching Every Child 
2013-17 
 
2016 MoHFW, and NHM, GoI 
MoHFW, GoI 
Vaccine and program 
specific operational 
guidelines (7) 
 Mission Indradhanush, 
Operational Guidelines 
2015 NHM, GoI 
 Intensified Mission 
Indradhanush (IMI), 
Operational Guidelines 
2018 MoHFW, and NHM, GoI 
 Operational Guide Japanese 
Encephalitis Vaccination in 
India 
2012 NHRM, GoI 
 Introduction of Measles –
Rubella Vaccines, Campaign 
and Routine Immunization 
2017 MoHFW, and NHM, GoI 
 Operational Guidelines for 
Introduction of Inactivated 
Poliovirus Vaccine (IPV) 
2015 MoHFW, and NHM, GoI 
 Operational Guidelines 
Introduction of Rotavirus 
Vaccine in the Universal 
Immunization Programme in 
India 
2015 MoHFW, and NHM, GoI 




2014 MoHFW, and NHM, GoI 
FAQ booklets for 
communities (3) 
 FAQ on Immunization For 
Parents & Caregivers 
2017 MoHFW, and NHM, GoI 
 FAQ on Immunization, for 
Health Workers & Other Front-
line Functionaries  
2017 MoHFW, and NHM, GoI 
 FAQ on Immunization for 
Religious Leaders, Media 
Persons, CSOs, Influencers & 
Other Stakeholders 
 
2017 MoHFW, and NHM, GoI 
AEFI related documents 
(3) 
 AEFI Media Communication 
Protocol 
 ITSU and NHM, GoI 
 AEFI Surveillance and 
Response Operational 
Guidelines  
2015 MoHFW, and NHM, GoI  
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 National Quality Assurance 
Standards for AEFI 
Surveillance Program  
 
2016 MoHFW, and NHM, GoI 
Communication and 
Social mobilization 
related documents (8) 
 Social Mobilization, Lessons 
from the Core Group Polio 
Project in India,  
2012 USAID and CORE Group 
 Intensification of Routine 
Immunization Communication 
Operational and Technical 
Guideline  
2012 NRHM, and MoHFW, GoI 
 Evaluation of Social 
Mobilization Network, Final 
Report Main Section 
2014 UNICEF 
 GAVI UNICEF Alliance 
Partnership Document with 
India 
2015 GAVI  
 CORE India Communication 
Strategy 
 
2017-2022 CORE India 
 Standard Operating 
Procedures for engaging with 
youth institutions for social 
mobilization for IMI and RI 
 Communication Guidelines for 
Building Vaccine Confidence 
around AEFI 
 Communication Guidelines for 








MoHFW, and Rotary 
International India 
National Polio Plus 
Committee 
NRHM, and MoHFW, GoI 
MoHFW, GOI, WHO, 
UNICEF and Rotary 
International India 
National Polio Plus 
Committee 
 
FAQ: Frequently Asked Questions, ITSU: Immunization Technical Support Unit, GoI: Government of India, MoHFW:  
Ministry of Health and Family Welfare, NHM: National Health Mission, NRHM: National Rural Health Mission, 
MoHFW, GoI, GAVI: The vaccine Alliance, UNICEF: United Nations International Children's Emergency Fund, USAID: 
United States Agency for International Development, WHO: World Health Organization  
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Table 8: Summary of Community Engagement (CE) Enablers and Barriers for Vaccination in India reported by 
National Decision-makers and Policy Documents by Levels of Socio-Ecological Model, 2018 
 
SEM Levels CE facilitators CE barriers 
Policy-level 
factors 
 Evidence of political-will for CE. 
 Evidence of direct communication 
between decision-makers and 
communities addressing vaccination 
related inquiries 
 Predominantly social mobilization 
approach, rather than CE 
 Adhoc CE interventions during AEFIs or 
any other emergency 
 Lack of any CE indicator  
 Lack of CE policy/strategy document 
 Lack of village level communication plan 
Community-level 
factors 
 Publication and dissemination of 
targeted SBCC materials 
 Evidence of class, caste, gender, rural 
versus urban related power-structures in 
communities  
 Skewed power relations between 
communities and health staff or 
vaccinating authorities  
 Top-down power relations between NGOs 
and Government/donors  
 Lack of sub-population specific SBCC 
materials 
 Lack of family-centric strategies to 
promote consultative household level 
vaccination decision making 
 Lack of evidence in policy documents 





 Evidence of formal partnerships 
between national and local 
stakeholders (religious leaders, clubs, 
women's groups)  
 
 Lack of formalization of partnerships 
between national and local stakeholders 
(religious leaders, clubs, women's groups) 
 Lack of evidence of partnership aiming to 
strengthening CE 
 Lack of quality investment in 
understanding community sentiment and 
tailoring trainings and SBCC materials 
accordingly 
 Lack of consistent strategic planning or 





 Evidence of evolution of sensitive 
messaging in vaccination related IPC 
and SBCC documents 
 MI logo  
 Evidence of utilization of social media 
as much as traditional media for SBCC 
 Tailored SBCC with men and mothers in 
law, considering the patriarchal setting 
in India  
 Lack of any mention of social-media 
proliferation in policy documents  
 FAQ documents, irrespective of the target 
group had the same language and 
presentation 
 No evidence of replicating SBCC 
interventions during Polio campaigns for 
new vaccines 
 Complex language in AEFI documents  
 Decision-makers did not take ownership 
of contested vaccines or any AEFIs 




  Non-vaccination or lack of CE was mostly 
positioned as the community’s fault 





Figure 1:  
 
Source: Adapted from the Handbook for Vaccine & Cold Chain Handlers Mininstry of Health and Family Welfare, 
India 2015 
ANM - Auxiliary Nurse and Midwife; ASHA - Accredited Social Health Activists; AWW - 
Anganwadi Worker; MoHFW - Ministry of Health and Family Welfare; ITSU - The Immunization Technical Support 
Unit; MoHFW - Ministry of Health and Family Welfare NTAGI - National Technical Advisory Group on Immunization 
in India; SMNet - Social Mobilization Network; UNICEF - United Nations Children's Fund; WHO - World Health 





















































































































































































































































































































































































































































































































































Adverse Event Following Immunization 
ASHA Accredited Social Health Activists 
ANM Auxiliary Nurse and Midwives 
AWC Anganwadi Center 
AWW Anganwadi Worker 
BCC Behavior Change Communication 
BCG Bacille Calmette-Guerin vaccine 
BRIDGE Boosting Routine Immunization Demand Generation 
C4D Communication for Development 
CBO Community Based Organization 
CDC Center for Disease Prevention and Control 
CE  Community engagement 
CHW Community Health Worker 
CGPP CORE Group Polio Project 
CSO Civil Society Organization 
DPT Class of combination vaccines against three infectious diseases in humans: 
diphtheria, pertussis, and tetanus 
EPI Expanded Programme on Immunization 
GAVI Gavi, the Vaccine Alliance 
GoI Government of India 
GVAP Global Vaccine Action Plan 2011-2020 
HPV Human Papillomavirus 
IAP Indian Academy of Pediatrics 
IAVI International AIDS Vaccine Initiative  
ICGEB International Centre for Genetic Engineering and Biotechnology 
IEC Information Education Communication  
IMI Intensified Mission Indradhanush 
IPC Interpersonal Communication 
ITSU Immunization Technical Support Unit 
KFT Knowledge Flow Theory 
LMIC Low and Middle Income Countries 
MoHFW Ministry of Health and Family Welfare, India 
MI Mission Indradhanush 
M-R measles and rubella virus vaccine 
MOU Memorandum of Understanding 
MSG Mission Steering Group 
NCR National Capital Region 
NGO Non-Governmental Organization  
NIH National Institutes of Health 
NTAGI National Technical Advisory Group on Immunisation in India 
NCC National Cadet Corps 
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NHM National Health Mission  
NPSP National Polio Surveillance Project 
NSS National Service Scheme 
NYK Nehru Yuvak Kendra 
PDS Public Distribution System 
SBCC Social Behavior Change Communication 
SEM Social Ecological Model 
SHG Self Help Group 
SMNet Social Mobilization Network 
SC Scheduled Caste 
SOP Standard Operating Procedure 
ST Scheduled Tribe 
ToT Trainin g of Trainers  
UNICEF United Nations Children's Fund 
UIP Universal Immunization Program 
VHND Village Health and Nutrition Day 




APPENDIX B: DEFINITION OF STUDY TERMS 
‘Community’ refers to define vaccine user communities. Specifically, this will include: 1) parents 
of vaccine eligible children, who have a surrogate vaccination decision-making role; pregnant 
women, adolescent children and other adults eligible for certain adult vaccines, who have a 
joint or individual vaccine decision-making role and those who might be in different risk-benefit 
profiles who utilize or are potential users of vaccines provided through the Government’s 
immunization programs, available for free. It will also include 2) community based 
organizations (CBOs), parents’ teachers’ associations, mother-in-law and daughter-in-law 
dyads, Community Advisory Boards (CABs), adolescent health focused groups like Kishori 
Panchayats and the likes working towards improving vaccination utilization among the vaccine 
eligible and potential user communities.  
 
‘Community engagement’ refers to efforts by people with vaccine policy standing in 
India to 'involve', ‘consult’ and ‘collaborate’ with community members and community 
stakeholders as self-determining actors in ways that lead to their own understanding 
and uptake of strategies and actions to improve their vaccination decisions for 
themselves and their children. Here I have also examined if community engagement is 
just with the motive to increase vaccine demand generation or increased participation 
in government run vaccination campaigns, or is there any evidence of a fundamental 
shift in how the government perceives communities and works with them. We will also 
see if the communities engaged in the longer run will become more responsive to 
immunizations, especially in the case of new vaccines. The study would not visualize 
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this shift as a revolution, but rather as a sustainable and incremental evolution process 
based on the externalities, existing circumstances, and allowing community agency to 
mature and develop.  
 
‘Community-level/Based Organizations’ (CBOs) are formal or informal institutions like 
women’s SHGs,   with public health functions, who are located in the community, and 
are both socially and/or spatially defined with particular shared characteristics (such as 
geographic location, cultural practices, beliefs etcetera). These CBOs consists of 
different members of the community who are members of these institutions based on 
self-identification and/or external attribution. 
 
‘Vaccine decision-makers’ or ‘elites’, are persons who have been in positions of authority (>7-
10 years) and have been responsible for formulating and approving the vaccine policy, vaccine 
specific guidelines, and programs in India, have signed off the introduction and roll out of 
vaccines under the UIP, have played decisive roles in improving vaccine related communication 
in all vaccine related Social and Behavior Change (SBCC) materials, and few who have led 
vaccine clinical trials between 2010 to current times. Most of them have also been part of 
vaccine ethics committees, and other advisory technical groups in India, or the Asia Pacific 
regions. These institutions/agencies the elites work could be classified into five broad kinds: 
National-level Ministries and Departments of the Government of India, technical advisory 
groups, UN agencies, donors, and international development organizations.  
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‘Vaccine policy documents’ refers to any national-level vaccine policies, vaccine strategy 
documents, Frequently Asked Question documents on vaccines for different stakeholders, 
Adverse Event Following Immunization, and vaccine specific guideline documents in India. 
These documents address immunization goals, and sensitize stakeholders and communities on 
vaccination gains. They are jointly published by the MoHFW and the National Health Mission 
(NHM), country offices of the World Health Organization (WHO), United Nations International 
Children’s Emergency Fund (UNICEF), and/or the CORE Group Polio Project (CGPP), during 2010 
to current times. Accordingly, most of these vaccine policy documents were either available on 
the website of the Ministry, or the National Technical Advisory Group on Immunization (NTAGI), 
or the Immunization Technical Support Unit (ITSU). While all the documents were available 
both in English (the official/professional language mostly practiced in India) and Hindi (the 
constitutionally approved national and official language of India), only the English version of 
these vaccine policy documents were included and reviewed in this study.  
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APPENDIX C: IRB EXEMPT STATUS  
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APPENDIX D: (1) KEY INFORMANT INTERVIEW GUIDE 
Introduction 
 
I am Tapati Dutta, a doctoral candidate at the school of public health at Indiana University-
Bloomington, U.S.A. Thank you for taking time to participate in this study. As you already know, 
this is for my doctoral research. I hope you received the information sheet about the study. 
Have you had a chance to review this?  
If yes, do you have any questions about this study? [Pause to discuss questions] 
If no, please take a moment to review this information (give information sheet. After review): 
Do you have any questions about this study? [Pause to discuss questions] 
 
Now that you have reviewed and discussed the study information, will you agree to participate 
in this interview? 
If no, we conclude the interview with thanks. 
If yes, May I begin and start the recording? 
 
[Start the recording] 
 
Part I:  Understanding community engagement  
1. Briefly describe your institution’s history with community engagement to improve 
vaccination uptake in India since 2010.  
 
a. [Probe]: With which/what communities or groups does your agency tend to work? 
b.  [Probe]: Please describe this relationship with the abovementioned community group/s.  
c.  [Probe]: How was this relationship formed   
d.  [Probe]:  How has your agency/institution engaged communities in vaccine decisions?  
  
2. In your opinion, how does your agency/institution define community engagement? 
 
a. [Probe]: How are the values of outreach and engagement reflected in your institutional 
mission statement and/or strategic plan, institution’s structure and governance? 
b. [Probe]: How is this similar or different from your own views? 
c. [Probe]: How has this changed over time?  
d. [Probe]: Is this the same across vaccines? 
 
3. How would you think the leader or senior management in your agency/institution 
supported advancing community engagement for vaccines? 
 
a. [Probe]: Can you give some examples that characterize leadership strategies and 
activities to advance outreach and engagement at national, state and local levels? 
b.  [Probe]: Would you also like to mention if there are any example since 2010 where 
community engagement has not been supported [appropriately] and how the leadership in 
your agency/institution, addressed it?  
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4. In what ways does your agency/institution partner with private sector, NGOs, 
communities and media to support and advance community engagement for vaccination 
acceptance and uptake?  
 
a.  [Probe]: Are these partnerships institutionally driven, or are they driven by a few 
leaders?  
b.  [Probe]: Who do you think are the leaders, advocates and gate-keepers in community 
outreach and engagement who are not formally charged but who are highly visible? Can you 
give me some examples? 
 
Part II: Understanding the enablers and barriers of community engagement for vaccine 
introduction and uptake  
Please describe the financial resources and trained human resources at all levels in your 
agency/institution to advance community engagement for vaccines? 
 
a.  [Probe]: What are the key financial and human resources for effective community 
engagement?  
b.  [Probe]: What would you think as key barriers for adequate financial and human 
resources for effective community engagement?  
 
What are your thoughts on communities’ level enablers to promote community engagement, 
especially for new and emerging vaccines?  
 
[Probe]: Please give some examples 
 
What are your thoughts on communities’ level myths and misconceptions which are or could be 
barriers to community engagement for new and emerging vaccines?  
 
[Probe]: Please give some examples  
 
[Probe]: Please give examples of social messaging, community sensitization, community 
mobilization to address such misinformation and build community’s trust for the vaccine 
delivery system and for new and emerging vaccines 
 
In your opinion what more can your agency/institution do to build a more enabling 
environment within your agency/institution to advance community engagement in vaccine 
introduction and delivery? 
 
[Probe]: Please give some examples 
 
Any additional comments? 
If yes [interview will continue] 
If no: 
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We have completed the interview. Thank you for your time and the information which you 
provided. Once the study is completed, I will share the findings with you once we have 
published them. 
  
In the course of analysis, may I contact you briefly if I have additional questions about your 
comments? 
 
Thanks again for your time. [Turn off the recorder]. 
 
End of interview 
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Via email  
 
RE: Interview request for a study about community engagement in vaccine planning and policy 
 
Dear Title [name], 
 
I write to invite you to participate in a brief [30 minutes] interview to discuss your 
institution/agency’s experience with and engagement of communities in vaccine policy and 
planning. This interview is part of my doctoral dissertation research on ‘Decision-makers’ 
Ownership and Support of Community Engagement to Improve Adoption and Uptake of New 
and Emerging Vaccines in India’. I have enclosed study information for your consideration. Dr. 
Beth Meyerson and Dr. Priscilla A. Barnes are the co-chairs of my dissertation committee. 
 
India has made tremendous progress during our “Decade of Vaccines” (2010-2020) by 
introducing multiple new vaccines along with increasing access to new and underused vaccines. 
Despite our progress, vaccine uptake is less than it should be. Understanding community 
engagement in vaccine policy and planning may help to identify opportunities to further 
advance our vaccine efforts.  
As a citizen of India, and a committed socio-behavioral scientist in community health, I have 
worked with Indian non-profit organizations for 15 years on issues of HIV and cervical cancer 
prevention as well as promoting use of prevention tools among the rural and vulnerable sub-
populations of women and girls.  
 
You are invited to participate in an interview because of your commendable vision and 
advocacy for vaccines in India. If you agree to participate in this study, please reply to this email 
and indicate your availability (dates/times) during this period:  December 6, 2017- January 26, 
2018. I will be in India during this time period, but can also arrange for an online/video 
interview if this is better for you.  
I am hopeful for your decision to participate in a brief interview, and look forward to sharing 







Research Associate, Rural Center for AIDS/STD Prevention  
Indiana University School of Public Health-Bloomington  
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APPENDIX E 
My Village My Home, Published by MCIP with USAID support: Vaccination Monitoring Tool by the 
Community  
 
 
